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Abstract 
EXPRESSIVE WRITING AS A THERAPEUTIC PROCESS FOR DRUG 
DEPENDENT WOMEN 
 
by Sarah Meshberg-Cohen, M.S. 
A dissertation submitted in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy at Virginia Commonwealth University. 
 
Virginia Commonwealth University, 2009 
Major Director: Dace S. Svikis, Ph.D., Professor, Department of Psychology 
 
            Women with Substance Use Disorders (SUD) have high rates of trauma and 
PTSD, which is linked to greater physical and mental health problems and poorer SUD 
treatment outcomes.  While research affirms trauma should be addressed during SUD 
treatment, the majority of addiction programs do not offer such services. One promising 
intervention is Pennebaker‘s expressive writing paradigm, which includes disclosure of 
traumatic/stressful experiences through 20-minute writing sessions over 3-5 consecutive 
days.  While expressive writing has been linked to improvements in mental and physical 
health, the intervention has not been studied in persons with SUDs.  The present study 
was a randomized clinical trial comparing expressive writing to control (neutral topic) 
writing.  Conducted in a residential SUD program for women, the study: 1) compared 
psychological and physical health profiles in SUD women with and without co-morbid 
PTSD and/or trauma; 2) compared 2-week and 1-month outcomes for the experimental 
and control groups; and 3) examined immediate and more distal levels of psychological 
distress following expressive writing.  Study participants were N=149 women 
 xii 
randomized to either the expressive writing or control writing condition.  All women 
completed 20-minute writing sessions daily for 4 consecutive days. As predicted, SUD 
women reported high rates of trauma and PTSD, and those with such co-morbidities had 
more severe psychological and physical health problems.  At 2-week follow-up, 
expressive writing participants showed greater reductions in post-traumatic symptom 
severity and anxiety scores than control writing participants.  While no group differences 
were found at 1-month follow-up, this was due largely to significant improvements for 
both groups over the course of residential treatment.  Finally, expressive writing 
participants showed increased negative affect immediately after each writing session, but 
there were no differences in pre-writing negative affect scores between groups the 
following day.  By the final writing session, participants were able to write about 
traumatic/stressful events without having a spike in negative affect.  Study results suggest 
expressive writing may be a brief, cost effective, adjunct to SUD treatment.  Furthermore, 
expressive writing, when implemented in a residential SUD setting, appears safe, and 
warrants further study as a strategy for addressing trauma and PTSD in tandem with SUD 
treatment.  
 1 
Introduction 
Epidemiological surveys and clinical studies point to overwhelming rates of 
interpersonal trauma in the lives of women with Substance Use Disorders (SUDs).  As 
many as 80% of women needing treatment for drug problems report lifetime histories of 
physical and/or sexual assault (Hien, Cohen, & Campbell, 2005), and many display 
Posttraumatic Stress Disorder (PTSD) symptomatology (Gilbert, El-Bassel, Schilling, & 
Friedman, 1997; Brown, Recupero, Stout, 1995; Brown, Stout, & Mueller, 1999).  In 
these settings, 55% to 99% of women report at least one lifetime trauma (Najavits, Weiss, 
& Shaw, 1997).  Trauma and addiction comorbidity studies consistently reveal these 
women are likely to have poorer health and increased disability, more severe clinical 
profiles, and worse treatment adherence, than those without traumatic experiences or 
PTSD (Najavits, 2006).  Greater rates of revictimization are found among females with 
SUDs compared to those without SUDs.  While trauma has traditionally not been 
incorporated into SUD treatment programs, studies indicate that addressing trauma 
during SUD treatment may improve treatment outcomes (Hien, Cohen, Miele, Litt, 
Capstick, 2004; Batten & Hayes, 2005; Brady, Dansky, Back, Foa, Carroll, 2001; 
Najavits, 2006).   
Accumulating evidence over the past two decades indicates that disclosure of 
traumatic or stressful experiences through expressive writing has widespread mental and 
physical health benefits.  Past studies have demonstrated the efficacy of expressive 
writing as a brief therapeutic intervention, with significant reductions in distress (Smyth, 
1998), and improved physical (Pennebaker, Mayne, & Francis, 1997) and psychological 
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health (Lepore & Smyth, 2002).  Beneficial effects related to writing about emotional 
experiences have been shown in areas as varied as health, achievement, and general well-
being (Slatcher & Pennebaker, 2006).   
Although much attention has focused on the benefits of Pennebaker‘s expressive 
writing paradigm, to date, expressive writing has not been examined in populations 
affected by SUDs.  Expressive writings‘ efficacy, efficiency (15-20 minutes per session 
over three to five consecutive days), and cost-effectiveness (the cost of a notebook), 
suggest that writing as a means for disclosing traumatic experiences may be a powerful 
adjunct to traditional alcohol and drug treatment, particularly in SUD treatment settings 
that do not routinely screen for trauma and PTSD and therefore, do not specifically focus 
on such issues during treatment.  To date, however, its usefulness as an intervention for 
SUD populations is unknown.  
The purpose of the present study is to examine whether Pennebaker‘s expressive 
writing paradigm is beneficial for women currently undergoing SUD treatment.  The 
expressive writing paradigm includes writing about an assigned topic daily for 20 minute 
sessions over four consecutive days. If expressive writing improves outcomes for women 
with SUDs, these findings would support its use as a brief, cost effective, adjunct to 
current SUD treatment. 
The present study begins with an extensive review of the literature on the co-
occurrence between trauma and substance abuse/dependence in women.  Next, theories 
behind the co-occurrence of trauma and SUDs, as well as the physical and psychological 
health implications are reviewed, with a discussion about the importance of addressing 
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trauma in conjunction with substance abuse treatment services.  Finally, expressive 
writing and disclosure as a therapeutic intervention is discussed, with a review of the 
various populations that expressive writing has been used with, and the possible 
mechanisms through which expressive writing may yield positive outcome results.   
Specific Aim 1: Investigate physical and mental health problems, as well as the 
relationships between PTSD and/or trauma and physical and mental health problems. 
Hypothesis 1:  Trauma symptom severity and/or PTSD will be associated with 
more significant physical health and psychological problems upon admittance to 
residential SUD treatment.   
Specific Aim 2: In a randomized clinical trial, the present study will compare 
outcomes for a treatment-based sample of substance abuse/dependent women assigned to 
either a written disclosure condition (emotional topic) or a control writing condition 
(neutral topic). 
Hypothesis 2: At two week and one month follow-ups, participants randomized to 
the expressive writing condition will show greater reductions in post-traumatic symptom 
severity, health symptoms, psychological distress, depressive symptoms, and drug 
cravings than participants randomized to the control writing condition. 
Specific Aim 3: Examine the influence of the expressive writing task on both 
immediate and longer-term levels of psychological distress. 
Hypothesis 3:  Women randomized to the expressive writing group will show 
higher levels of immediate distress (measured immediately after each writing session) 
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and lower levels of longer-term distress (measured at two and one month post-baseline 
assessment) relative to those in the control group.  
 5 
Review of the Literature 
Substance Use Disorders and Trauma  
Substance Use Disorders  
A Substance Use Disorder (SUD) is a subcategory of substance-related disorders 
that includes both Substance Dependence and Substance Abuse (DSM-IV-TR; American 
Psychiatric Association, 2000).  It includes disorders related to drugs of abuse ranging 
from alcohol to heroin.   
According to the Diagnostic and Statistical Manual, Fourth Edition, Text Revision 
(DSM-IV-TR; American Psychiatric Association, 2000), Substance Dependence involves 
a cluster of cognitive, behavioral, and physiological symptoms indicating that the 
individual continues to use the substance despite considerable substance-related 
problems.  Substance Dependence involves a maladaptive pattern of substance use 
causing clinically significant impairment or distress, as revealed by three (or more) of the 
following within a 12-month period: 1) tolerance; 2) withdrawal; 3) taking larger 
amounts of the substance over a longer period of time than intended; 4) persistent desire 
or unsuccessful efforts to cut down or control use; 5) great deal of time spent in activities 
necessary to obtain, use, or recover from the effects of the substance; 6)  important 
occupational, recreational, or social activities given up because of substance use; 7) 
recurrent use despite knowledge of having physical or psychological problems likely 
caused or exacerbated by the substance.     
Unlike the criteria for Substance Dependence, Substance Abuse does not include 
tolerance, withdrawal or a pattern of compulsive use, but rather it includes only the 
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harmful consequences of repeated use.  According to the DSM-IV-TR (American 
Psychological Association, 2000), the main characteristic of Substance Abuse is a 
maladaptive pattern of substance use exhibited by recurring and significant adverse 
consequences related to the continual use of substances.  It involves a maladaptive pattern 
of substance use causing clinically significant impairment or distress, as exhibited by at 
least one of the following within a 12-month period: 1) failure to fulfill major role 
obligations at school, work, or home due to recurring substance use; 2) repeated 
substance use in situations that are physically hazardous (e.g. driving, operating 
machinery); 3) repeated substance-related legal problems; 4) recurring substance use 
despite having continual or repeated interpersonal or social problems caused or 
exacerbated by the effects of the substance (American Psychological Association, 2000). 
In order to meet criteria for Substance Abuse, criteria for Substance Dependence must 
never have been met.   
Throughout this proposal, we refer to SUDs, which include either Substance 
Dependence or Substance Abuse of alcohol and other drugs. 
Substance Use Disorders and Women 
Historically, SUDs were thought to primarily affect men, and the majority of SUD 
studies were conducted predominantly with male subjects.  However, the gap between the 
proportion of male and females with SUDs has been narrowing, and recent studies show 
an increase in numbers of women with drug abuse problems (Gutierres & Van 
Puymbroeck, 2006).  Even though women are less likely than men to have opportunities 
to use drugs, when given the opportunity to use drugs for the first time, women and men 
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are equally likely to do so and to progress from initial use to addiction (Van Etten & 
Anthony, 2001).  While rates of SUDs remain higher in men versus women, about 7 
million American women between 15 and 54 years of age have a lifetime SUD, with over 
4.4 million American women considered to be currently drug dependent.  Of these 4.4 
million American women, 2.5 million meet criteria for current drug abuse, representing 
over 30 percent of the illicit-drug-using population (Turner & Wallace, 2003; United 
Nations Office on Drugs and Crime; UNODC, 2004).   
Although SUDs are a rising health concern among females, women are 
underrepresented in most SUD treatment programs (Greenfield, et al., 2007).  Because 
most drug treatment programs were originally created to address issues common to 
males, the treatment and research communities have recently recognized the need to 
identify and better understand gender differences in the etiology of substance use and 
substance use treatment needs and treatment utilization, with particular attention to the 
effectiveness of various SUD treatment services for women (Pelissier & Jones, 2005).   
Recent research focused on women with SUDs has revealed numerous sex 
differences (Lynch, Roth, & Carroll, 2002).  Females frequently encounter a greater 
number of barriers to treatment-seeking than their male counterparts.  Main barriers to 
treatment among women includes concerns about childcare, transportation, social stigma 
and labeling, a lack of awareness of the variety of treatment choices, problems with the 
confrontational models used by some SUD programs, time and economic costs of 
treatment, and stereotypical ideas of clients of treatment services (Copeland, 1997).  Such 
obstacles may contribute to the fact that by the time they present for treatment, women 
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generally present with higher levels of addiction severity and more severe co-morbidities 
than men (Copeland, 1997).  Women are also more likely than men to seek treatment for 
drug abuse problems in a mental health facility than in a SUD treatment program (Lynch, 
Roth, & Carroll, 2002).  In addition, studies suggest that women generally show greater 
psychological distress, greater addiction severity, more medical problems, and fewer 
occupation marketable skills than men at the time of treatment entry (Arfken, Klein, di 
Menza, & Schuster, 2001).   
Studies addressing gender differences in post-treatment outcomes have revealed 
mixed results, with some studies showing women and men with comparable outcomes 
(Alterman, Randall, McClellen, 2000; Gerstein and Johnson, 2000), while other studies 
support one gender over the other (Arfken, et al., 2001; Grella, Scott, Foss, Joshi, Hser, 
2003; Gutierres & Van Puymbroeck, 2006; Niv & Hser, 2007).  For instance, Alterman 
and colleagues (2000) compared 7-month post-treatment entry of nine community 
programs (N = 294; n = 145 female) and found few gender difference outcomes.   
On the other hand, some studies find that, compared to men, women fare worse in 
drug SUD treatment programs, and have significantly lower rates of treatment entry, 
treatment retention, and successful treatment completion (Arfken, et al., 2001; Grella, et 
al., 2003; Gutierres & Van Puymbroeck, 2006).  For instance, in addition to finding more 
severe problems among women than men at assessment, Arfken and colleagues (2001) 
examined a publicly funded SUD treatment system (N  = 2,741), and found that women 
had significantly lower treatment completion rates and 30-day retention in treatment than 
men.   
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Given the recognized obstacles and problems that women have in substance use 
treatment programs, it is important to better understand the issues that may account for 
these difficulties (Gutierres & Van Puymbroeck, 2006).  Types of issues to be addressed 
during treatment with females with SUDs should acknowledge the comprehensive range 
of women‘s problems (Pelissier & Jones, 2005).   One of the most commonly 
documented factors by researchers is the link between trauma and drug addiction in the 
lives of women (Gutierres & Van Puymbroeck, 2006).   
Trauma and Posttraumatic Stress Disorder (PTSD) 
A traumatic event is defined as an emotionally disturbing and distressing event 
beyond the range of normal human experience, which can be experienced first-hand or 
witnessed, and can include child abuse, sexual assault, domestic violence, military 
combat, and a host of other violent incidents (MIMH fact sheet, 2004).  While men are 
generally more likely to be exposed to traumatic events during their lifetime, women are 
more likely to endure chronic high impact trauma such as physical abuse, childhood 
sexual violence, and neglect (Stewart, Ouimette, & Brown, 2002).  Not all people who 
experience traumatic events go on to develop PTSD; however, once exposed to trauma, 
women are about twice as likely to develop PTSD compared to men, and the traumatic 
events experienced by women are also qualitatively different from those experienced by 
men (Stewart, et al., 2006).    For instance, data from the National Comorbidity Survey 
(NCS), a nationally representative U.S. epidemiological study of people ages 15 to 54 
years old (N = 5388), revealed that approximately 61% of men were exposed to trauma 
 10 
compared to 51% of women, however, only 5% of men compared to 10% of women met 
DSM-IV diagnostic criteria for PTSD (Kessler, et al., 1995).   
According to the DSM-IV, PTSD is a psychiatric disorder, which a person may 
develop after experiencing or witnessing a severe or life-threatening event (American 
Psychiatric Association, 2000).  The essential characteristics of PTSD involve the 
development of symptoms following the experience of an acute stressor involving direct 
personal experience of an event that includes actual or threatened death or serious injury, 
or other threat to one‘s physical integrity; or observing an incident that involves injury, 
death, or a threat to the physical integrity of another person; or learning about serious 
harm, a sudden or violent death, or threat of injury or death experienced by a close 
associate or family member (Criterion A1).  The individual‘s reaction to the incident 
must include helplessness, extreme fear, or horror (Criterion A2) (American Psychiatric 
Association, 2000).  The characteristic symptoms resulting from the exposure to the 
extreme trauma include persistent  re-experiencing (e.g., flashbacks, hallucinations, 
illusions, dreams, etc.) (Criterion B), avoidance/numbing (e.g., avoiding thoughts, 
feelings, activities, places, or people or conversations associated with the trauma, etc.) 
(Criterion C), and hyperarousal (e.g., irritability/outbursts of anger, hypervigilance, 
exaggerated startle response, etc.) (Criterion D) relating to the original trauma, which 
must be of at least one month duration (Criterion E) and associated with impaired 
functioning (Criterion F) (Reynolds, et al., 2005; American Psychiatric Association, 
2000).  
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There is currently a lot of heterogeneity in the literature looking at trauma versus 
PTSD.  For the purposes of this proposal, the review of the literature will specify whether 
the particular study identifies PTSD or trauma.   
Substance Use Disorders and Trauma among Women 
Epidemiological surveys and clinical studies point to overwhelming rates of 
interpersonal trauma in the lives of women with SUDs.  The high co-occurrence of 
traumatic stress exposure and SUDs is increasingly evident.  As many as 80% of women 
needing treatment for drug problems report lifetime histories of physical and/or sexual 
assault (Dansky, Saladin, Brady, Kilpatrick, & Resnick, 1995; Hien, Cohen, & Campbell, 
2005), and many display PTSD symptomatology (Brown, Recupero, Stout, 1995; Brown, 
Stout, & Mueller, 1999; Gilbert, El-Bassel, Schilling, & Friedman, 1997).   
Epidemiological studies reveal that SUDs are 3.1 to 4.5 times more likely among 
women with PTSD compared to those without PTSD (Kessler, Sonnega, Bromet, 
Hughes, & Nelson, 1995).  Rates of current PTSD among women in substance treatment 
settings range from 30% to 59% (Najavits, et al., 1997), compared to PTSD rates in the 
general population ranging from 1% to 9% (Kessler, et al., 1995).  In addiction treatment 
settings, 55% to 99% of women report at least one lifetime trauma (Najavits, et al., 1997).  
Greater rates of revictimization are also found among females with SUDs compared to 
those without SUDs (Dansky, Brady, & Saladin, 1998).  The proposed study will 
determine rates of trauma and PTSD-related symptomatology in a residential treatment 
sample of SUD women.  
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Childhood Trauma and Women with Substance Use Disorders 
Research suggests that the majority of women with comorbid SUD and PTSD are 
victims of childhood trauma (Brown & Wolfe, 1994), and are likely to experience 
repeated traumatic events in adulthood (Cohen & Hien, 2006).  Female drug users, more 
often than males, are found to have high rates of violent victimization as children and as 
adults (Guiterres & Van Puymbroeck, 2006).  These trends are seen across various drug 
using populations.  For instance, one study examining residential male and female drug 
abuse patients (N = 146; n = 72 women) found that 79% of women versus 41% of men 
reported childhood emotional abuse, 51% of women versus 23% of men reported 
childhood physical abuse, and 52% of women versus 7% of men reported childhood 
sexual abuse (Gutierres & Todd, 1997).  In a residential drug treatment facility (N = 178), 
84% of female and male patients reported a history of childhood sexual or physical 
assault (Cohen & Densen-Gerber, 1982).  In a prison population, childhood abuse (sexual 
abuse and/or physical abuse and/or neglect) was found to be a significant predictor of 
adult arrests for drug and alcohol related offenses for female prisoners, but not for male 
prisoners (Ireland & Widom, 1994).   
Women are also more likely than men to report that they started using drugs in 
order to mitigate trauma-related symptoms connected with abuse (Sheridan, 1996; 
Gutierres & Todd, 1997; Woodhouse, 1992), and are more likely to experience repeated 
trauma in later life (Dansky, Brady, & Saladin, 1998).  Studies consistently find that 
women who have experienced childhood sexual abuse are more vulnerable than non-
victims to be sexually abused as adults, and are more likely to endure physical abuse later 
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in life by their husbands and partners (Desai, Arias, Thompson, & Basile, 2002; Guterres 
& Van Puymbroeck, 2006).  Even after controlling for family background variables (e.g., 
parental alcohol problems) and treatment condition, rates of childhood victimization are 
shown to be higher for women in alcohol-related treatment (e.g., outpatient alcoholism 
clinics) compared to women in treatment for non-alcohol related problems (e.g., 
outpatient mental health clinics) (Miller, Downs, & Testa, 1993).  Of note, while rates of 
reported childhood trauma among women in SUD treatment programs is high, there is 
reason to believe that the real incidence is even higher, since studies that use multiple 
assessments show that some women who do not identify the abuse at intake, admit 
experiencing abuse later in treatment (Briere & Conte, 1993; Gutierres & Van 
Puymbroeck 2006).   
Adult Trauma and Women with Substance Use Disorders 
In addition to the high rates of child abuse reported among women seeking SUD 
treatment, it is also clear that these women experience a significant amount of trauma 
during adulthood.  For instance, Gilbert and colleagues (1997) examined adult 
victimization among women in methadone treatment (N = 151) and found that 88.7% had 
experienced physical abuse, 71.1% experienced having their life threatened, 25.3% 
experienced sexual abuse, and 42.9% experienced both physical abuse and having their 
life threatened.  While not all individuals with trauma go on to have PTSD, the majority 
of individuals in SUD treatment have significant trauma histories.   
In a study comparing SUD patients with and without comorbid PTSD, Brown and 
colleagues (1999) found that 95% of participants (N = 90), regardless of PTSD diagnosis, 
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had been exposed to significant trauma during their lifetime.  Reported traumas included 
catastrophic death of a loved one (e.g., homicide or suicide; 65%), childhood physical 
abuse (40%), childhood forced sexual touching (40%), and adulthood physical abuse 
(38%).  Women reported significantly more types of traumas than men (M = 4.0 vs M = 
2.8), and were significantly more likely than men to report physical abuse during 
adulthood (59% vs 14%) and forced sex during adulthood (31% vs 5%; Brown, Stout, & 
Mueller, 1999).   
Oftentimes, the traumatic events experienced by women are qualitatively different 
from those experienced by men, and women may be affected differently than men by 
similar events (Stewart, Ouimette, & Brown, 2002).  Najavits and colleagues (1998) 
examined rates of lifetime trauma and current PTSD symptomatology among treatment-
seeking cocaine dependent outpatients (N = 122; n = 43 females) from the National 
Institute on Drug Abuse Collaborative Cocaine Treatment Study, and found a large 
number of traumatic events (M = 5.7).  Women were significantly more likely than men 
to meet criteria for past month (current) PTSD (30% versus 15%, respectively).  Results 
also indicated gender differences in the types of trauma leading to PTSD, where women 
were more likely than men to experience physical and sexual abuse (M = 1.4 versus M = 
0.9, respectively), while men were more likely to report general disasters and crime-
related traumas than women (M = 3.9 versus M = 2.0, respectively).   
Similarly, Coffey and colleagues (1998) examined lifetime exposure to trauma 
among SUD patients (N = 118; n = 67 women) and found that women were more likely 
than men to report rape (37% of women versus 6% of men) and other sexual assault (25% 
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of women versus 11% of men), while men were significantly more likely than women to 
be exposed to combat trauma (10% of men versus 0% of women).   Another study 
examining residential drug dependent patients (N = 100; n = 50 females), found that over 
half (66%) of the sample had a sexual or physical assault history, with women being 
significantly more likely than men to have experienced sexual assault, serial assault, and 
familial assault (Grice, Brady, Dustan, Malcolm, & Kilpatrick, 1995).  Half of the assault 
victims, but none of those who did not experience assault, met criteria for PTSD.  
Findings also revealed that patients with a childhood abuse history started abusing drugs 
at an earlier age compared to those without a childhood abuse history (Grice, et al., 
1995).   
In a study focusing cocaine dependent patients (N = 91; n = 33 females), Dansky 
and colleagues (1999) found that 86% of patients reported a history of physical assault.  
There were no significant differences between men and women in terms of their 
likelihood of being physically assaulted; however, women were more likely than men to 
have been assaulted by a partner (76% versus 29%, respectively).  Women were also 
more likely than men to fear death or serious harm during aggravated assault without a 
weapon (94% versus 56%, respectively) and during simple assault (82% versus 18%, 
respectively) (Dansky, Bryne, & Brady, 1999).  In another study examining residential 
SUD patients (N = 84; n = 36 females), Brown and colleagues (1995) found that women 
were more likely than men to have experienced physical assault/abuse (31% versus 6%), 
sexual assault/abuse (25% versus 4%), and rape (25% versus 2%); women were also 
significantly more likely than men to meet criteria for lifetime PTSD (43% versus 12%).   
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While high rates of physical assault and PTSD are found among men and women 
with SUDs, women may be affected differently than men.  For instance, in an evaluation 
of gender differences in criminal victimization and crime-related PTSD rates among 
inpatient SUD adults (N = 95; n = 61 females), approximately 90% reported a history of 
physical and/or sexual assault (Dansky, Brady, Saladin, Killeen, et al., 1996).  Structured 
interviews were used to evaluate a lifetime history of crime-related victimization, which 
included sexual molestation, attempted sexual assault, completed rape, aggravated 
assault, and other physical assaults (e.g., serious physical attacks experienced prior to age 
18 that were perpetrated by a guardian) and PTSD.   While non-crime related events 
included serious accidents, natural disasters, homicide of a loved one, exposure to dead 
bodies, and witnessing the violent death of a person, in order to meet criteria for a crime-
related PTSD patients needed to have experienced at least one crime-related traumatic 
event and meet PTSD criteria.  Results revealed that women were more likely than men 
to have experienced rape (59% versus 21%, respectively), and were also more likely than 
men to have felt that their life was in jeopardy during the rape (89% versus 57%, 
respectively).  Overall, 53% of the women and men met diagnostic criteria for lifetime 
crime-related PTSD, with over 40% meeting criteria within the past 6 months (Dansky, et 
al., 1996).   
Other studies have found that having experienced more than one significant 
lifetime trauma is associated with an increased rate of PTSD.  For instance, Fullilove and 
colleagues (1993) looked at female drug users (N = 105) in treatment for SUDs, and 
found that almost all (n = 104 out of N = 105) of the women had experienced at least one 
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significant trauma, with 59% of these women meeting criteria for PTSD.  This study also 
found that 97% of women with PTSD reported one or more violent trauma compared 
with 73% of those without PTSD (Fullilove, et al., 1993).   
Domestic Violence and Women with Substance Use Disorders 
 Women with childhood abuse histories are more likely than those without such 
histories to end up in violent relationships when they get older.  Partner violence is a 
prevalent issue among women with SUDs, and up to 80% of women attending SUD 
treatment programs report a history of domestic violence (Bennett & Lawson, 1994; 
North, Thompson, Smith, & Kyburz, 1996).  For instance, one study examining violence 
in the lives of homeless mothers in SUD treatment found that 84% reported childhood or 
adult victimization (North, et al., 1996).  This study also revealed that while 60% of the 
women reported childhood physical or sexual abuse, 71% indicated adult victimization in 
the form of domestic violence or sexual abuse.   
A recent longitudinal study by Salomon and colleagues (2002) showed that 
women who experienced adult partner violence were nearly three times more likely to 
report illegal drug use at follow up than those not exposed to partner violence.  There was 
also a significant relationship between childhood abuse and domestic violence in later 
life, and the combination of childhood sexual abuse and resultant PTSD was a better 
predictor of substance abuse than either risk factor alone (Salomon, Bassuk, & 
Hintington, 2002).  While some drug abusing women who are in violent relationships end 
up in SUD treatment programs, others may seek help from domestic violence programs.  
A randomly selected sample of 74 programs for SUDs or domestic violence revealed that 
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60% of female drug abusers were victims of domestic violence, and 42% of women in 
domestic violence programs were abusing drugs (Bennett & Lawson, 1994).    
High Co-Occurrence Theories 
The presence of either problem (SUD or PTSD) can increase the risk of 
developing the other disorder, and these findings are consistent across various kinds of 
traumas and substances of abuse (Najavits, Weiss, & Shaw, 1997).  While high 
comorbidity rates indicate that PTSD and SUDs are functionally related, the mechanisms 
underlying the development of this relationship is not clear (Back, Brady, Sonne, 
Verduin, Back, et al., 2006).   
Three main pathways have been used to account for these high rates of 
comorbidity.  While alcohol and drugs may be used to self medicate to avoid trauma 
reminders and related distress, the lifestyle of someone with drug use problems may 
predispose these individuals to endure traumatic events (Johnson, Striley, & Cottler, 
2006; Reynolds, et al., 2005).  Another theory suggests that an independent third factor, 
such as genetic and/or environmental influences, may contribute to the high co-
occurrence of both problems (Brown & Wolfe, 1994; Xian, et al., 2000).  The proposed 
study will examine whether trauma is related to drug craving among women in a 
residential SUD treatment facility. 
Self-Medication Theory 
 The self-medication hypothesis suggests that people with trauma histories and 
related PTSD symptomatology use drugs in an effort to help them avoid or cope with 
upsetting symptoms and to reduce painful feelings or physiological sensations (Hien, 
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Cohen, & Campbell, 2005).  Khantzian‘s (1985) proposed self-medication theory of 
addictive disorders theorizes that drugs are chosen for use according to their particular 
psychotropic effects (e.g., cocaine may alleviate depressive symptoms, while heroin may 
alleviate anxiety and aggressive feelings).   Exposure to extreme trauma, particularly 
during childhood, may disrupt self-regulatory processes and cognitive systems, and such 
deficits have been associated with initiation and continuation of SUDs (Hien, Cohen, & 
Campbell, 2005).  Thus, self-medicating with drugs and alcohol can decrease the 
hyperarousal and numbing effects by masking symptoms of PTSD and providing 
temporary relief from dysregulated feelings (e.g., Khantzian & Schneider, 1986).   
In support of the self-medication hypothesis, a longitudinal study of adults aged 
21 to 30 (N = 1007), who were initially assessed in 1989 and followed up 3 and 5 years 
later, revealed that preexisting PTSD signaled an increased risk of SUDs (hazards ratio = 
4.5; Chilcoat & Breslau, 1998).  Chilcoat and Breslau (1998) used a prospective design 
and analytic strategies for testing causal inference, and found that SUDs in individuals 
with PTSD might be the unplanned result of efforts to medicate symptoms.  Similarly, an 
epidemiologic study, using a co-twin design, found that regardless of being raised in the 
same family upbringing, a twin who was exposed to childhood sexual abuse had a 
significantly elevated risk for SUDs when compared to her unexposed twin, supporting a 
causal interpretation of the association between childhood sexual abuse and SUDs 
(Kendler, et al.  2000).  A longitudinal study by Kilpatrick and colleagues (1997) also 
found that sexual and physical abuse led to drug misuse, and that active drug use was 
associated with an increased risk of victimization.   
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Some studies have found a direct causal pathway between childhood abuse and 
drug abuse.  Schuck and Widom (2001), for example, used structural equation modeling 
in a sample of women (N = 582) who had endured childhood victimization, and found 
that childhood abuse played a causal role in alcohol symptoms among women, which was 
mediated by depression as well as the use of drugs or alcohol to cope.  In another study, 
Brady and colleagues (1993) found that trauma and PTSD appeared prior to the onset of 
SUDs for the majority of women (78%) and men (73%), which revealed temporality data 
that are compatible with the self-medication theory for both genders.  Finally, in a 
comprehensive review by Stewart (1996), results showed that individuals exposed to 
trauma, specifically those suffering from PTSD, were at a higher risk for developing 
alcohol problems than those not exposed, and that the most common explanation 
suggested to account for the comorbidity is that alcohol was being used to self-medicate 
symptoms of PTSD.  While there is empirical support for the self-medication model 
(Hien, Cohen, & Campbell, 2005), another pathway, such as the high-risk and 
susceptibility theory, has also been suggested.   
High-Risk and Susceptibility Theory 
 The high-risk and susceptibility theory suggests that drug use and related high-
risk behaviors increase the risk to traumatic encounters, thus circuitously enhancing the 
probability of trauma and PTSD-related symptomatology (Hien, Cohen, & Campbell, 
2005).  This pathway suggests that drug abuse may precede PTSD.  As women engage in 
the drug market, their dependence on drugs escalates and their lives generally become 
characterized by greater social chaos, where violence, sexual degradation, and fatality are 
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elements of the drug life.  Ongoing drug and crime interactions put women at high risk 
for assault, rape and death when compared to women who do not use drugs (Boyd, Hill, 
Holmes, & Purnell, 1998).  
Chronic drug use can also produce elevated levels of anxiety and arousal as well 
as sensitization of neurobiological stress systems, and may cause a higher level of 
susceptibility to the progression of PTSD after trauma exposure (Jacobsen, Southwick, & 
Kosten, 2001).  Thus, drug abusers may be more vulnerable to PTSD after a traumatic 
event due to impaired neurochemical or psychological systems stemming from persistent 
drug use (Hien, Cohen, & Campbell, 2005).  These associations between drug use and 
trauma do not necessarily suggest that SUDs always happen prior to exposure to 
traumatic events and PTSD, but rather, that there is a vicious cycle of events, which in 
many cases, can start with drug use (Johnson, Striley, & Cottler, 2006).   
Johnson and colleagues (2006) recently found that drug use was a precipitant to a 
traumatic event in a sample of out-of-treatment African American drug users (N = 1098), 
with 16% of the sample with trauma and poly-drug use reporting that the onset of all drug 
use (with the exception of crack cocaine) occurred prior to the trauma.  In a longitudinal 
investigation examining the association between intimate partner violence and SUDs 
among women (N = 724) ages 18 to 30, both ―hard‖ drug use and marijuana use were 
related with an increased risk of experiencing violence in new relationships (Testa, 
Livingston, & Leonard, 2003).  Cottler and colleagues (1992) also found that physical 
assault often triggered PTSD among cocaine abusers, and that drug use preceded the 
onset of PTSD symptomatology.  Furthermore, their study showed that opiate and 
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cocaine users were over three times more likely to endure a physical assault than the non-
drug using comparison subjects matched on traumatic experiences, and were more likely 
than the comparison subjects to develop PTSD as a result of these events (Cottler, 
Compton, Mager, Spitznagel, & Janca, 1992).  Finally, a significant number of women 
with SUDs are involved in intimate relationships with other drug and alcohol abusers, 
and drug problems of the abusive partner may play a role in both violence and in the 
woman‘s own drug abuse problems (Giles-Sims, 1998).   
Third Factor Theory 
It has also been suggested that overlapping genetic and environmental influences 
are possible contributing factors to the common etiology of SUDs and PTSD (Brown & 
Wolfe, 1994; Xian, et al., 2000).  In a review of co-occurring SUDs and PTSD, Brown 
and Wolfe (1994) concluded that SUDs and PTSD are multifactorial in etiology, and that 
in order to understand this co-occurrence, it is necessary to take into account biological, 
environmental, and psychological factors.  Research using family, adoption, and twin 
samples identify a genetic influence on alcohol dependence (Kendler, et al., 1997; 
Pickens, et al., 1991), drug dependence (Grove, et al., 1990; Pickens, et al., 1991), and 
trauma exposure and PTSD (Jang, et al., 2003; Reich, et al., 1996; Stein, et al., 2003).  
Recently, Xian and colleagues (2000) published a study that investigated the 
degree to which environmental and genetic influences contributed to the lifetime co-
occurrence of  SUDs and PTSD in a study of monozygotic and dizygotic male-male twin 
pairs members (N = 3304) who were members of the Vietnam Era Twin Registry.  Using 
a genetic model fitting, Xian and colleagues (2000) found that SUDs and PTSD had 
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etiologically distinct components as well as significant genetic and specific 
environmental contributions in common.  Specifically, they found that the liability for 
PTSD was partly owing to a 15.3% genetic contribution common to drug and alcohol 
dependence and 20.0% genetic contribution specific to PTSD.  They also found that 
having a risk for alcohol dependence was partly due to a 55.7% genetic contribution that 
is common to drug dependence and PTSD.  Furthermore, genetic influences common to 
PTSD and alcohol dependence constituted 25.2% of the total risk for drug dependence, 
and certain family environmental influences accounted for 33.9% of the total variance in 
drug dependence risk.   
Implications of Co-Occurring Trauma and SUDs 
Trauma and Health among Women with SUDs 
While SUDs are associated with a wide range of physical and mental health 
detriments, PTSD confers an even greater risk and detriment.  Women with SUDs who 
have also experienced severe trauma have disproportionate physical health burdens, and 
are especially susceptible to risk factors related to poor health and disability (Larson, et 
al., 2005; Reynolds, et al., 2005).  These women generally report significantly more 
chronic physical symptoms, poorer health perceptions, and a higher rate of neurological 
and cardiovascular symptoms compared to those without PTSD (Ouimette, Goodwin, & 
Brown, 2006).   
For instance, Larson and colleagues (2005) found that almost half (48%) of the 
women in a cross-site study of specialized services for women with histories of trauma 
and co-occurring SUDs (N = 2,729) reported serious physical illnesses that frequently 
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restricted their daily life activities or required the use of special equipment.  Health status 
was rated as poor or fair among 46% of these women.  Ouimette and colleagues (2006) 
recently examined the effects of PTSD on health and well being among patients with 
SUDs and found greater cardiovascular and neurological symptoms in SUD patients with 
PTSD compared to those who did not have PTSD, even after controlling for ethnicity and 
gender.  SUD patients with comorbid PTSD also reported worse bodily pain and a greater 
number of chronic physical symptoms as well as poorer scores on general health as 
compared to SUD patients without PTSD (Ouimette, Goodwin, & Brown, 2006).   
Women with trauma histories are also more likely than women without trauma to 
be hospitalized with both trauma and non-trauma related medical problems.  For instance, 
in study examining childhood abuse and domestic violence among women in methadone 
maintenance treatment (N = 151), results indicated that a greater proportion of abused 
women than non-abused women reported being admitted to a hospital within the past 
three months and having had a major illness within the past three months (Gilbert, Bassel, 
Shilling & Friedman, 1997).   
The proposed study will assess the frequency of common physical symptoms and 
sensations, and expects to find that SUD women with PTSD symptomatology will 
experience greater health problems than SUD women without PTSD symptomatology, 
supporting the need for an intervention that may help improve health outcomes among 
SUD patients. 
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Clinical Profiles among Women with SUDs and Trauma  
In addition to health problems, studies consistently reveal that women with 
comorbid SUD and PTSD are likely to have greater addiction severity, higher rates of 
interpersonal and psychological problems, additional psychiatric disorders, lower global 
levels of functioning, a lower motivation for drug treatment, and poorer treatment 
outcomes than those without PTSD or significant trauma histories (Clark, Masson, 
Delucchi, Hall, & Sees, 2001; Coffey, Schumacher, Brimo, & Brady, 2005; Najavits, 
Weiss, & Shaw, 1997).   
For instance, among opiate dependent women in methadone treatment (N = 150), 
Clark and colleagues (2001) found that violent trauma and distress was highly correlated 
with severity of drug use (as measured by the Addiction Severity Index [ASI]).  
Furthermore, the use of ―harder‖ drugs, such as cocaine and heroin, are consistently 
found to show a stronger correlation with trauma and/or a PTSD diagnosis than other 
drugs, such as alcohol or marijuana (Grice, et al., 1995; Miller, Downs, & Testa, 1993).  
Women with comorbid SUDs and PTSD are also at increased risk for a range of other 
problems, including interpersonal deficits, custody battles and mistreatment of their 
children, HIV risk, homelessness, and domestic abuse (Brady, Dansky, Sonne, & Saladin, 
1998; Hien, Cohen, & Campbell, 2005).   
In a study comparing women (N = 57) with SUD and PTSD (dual diagnosis 
group; n = 28) to women with PTSD only (single diagnosis group; n = 29), Najavits and 
colleagues (1999) found more severe clinical profiles and interpersonal problems among 
the dually diagnosed individuals as compared to the other group.  Women with SUD-
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PTSD reported: worse life circumstances since childhood (e.g., fewer opportunities in 
life, less attractive physical appearance); more criminal behavior; more siblings with drug 
problems (50.0% versus 20.7%); and greater lifetime suicide attempts (78.6% versus 
51.7%).  Virtually all of the women (98%) with SUD-PTSD reported experiencing their 
first trauma prior to 18 years of age.  Furthermore, PTSD preceded SUD onset for the 
majority of women (61%), offering support for the self-medication hypothesis (Najavits, 
Weiss, & Shaw, 1999).   
Women with a history of PTSD are also more likely than those without PTSD to 
be diagnosed with depression and dysthymia, to report higher rates of depressive 
symptoms, and are more likely to have attempted suicide (Clark, et al., 2001).  Among 
inner-city, African American women, depressive symptoms are found to be greater 
among women who report both high levels of intimate partner violence and alcohol 
problems (Paranjape, et al., 2007).  Cross-sectional studies reveal that females with 
comorbid SUD-PTSD have significantly worse clinical profiles than females with only 
one of the two disorders (Brown, Stout, & Mueller, 1999; Najavits, Weiss, & Shaw, 
1999; Ouimette, Wolfe, & Chrestman, 1996).  Women with SUDs and current PTSD, 
compared to those without, have significantly higher rates of medical problems, 
interpersonal problems, show greater resistance to treatment, and have higher rates of co-
occurring axis I and axis II disorders, as well as higher levels of psychopathological 
symptomatology (Najavits, et al., 1999).   
In a well designed study that used both self-report and interview measures of 
psychopathology and substance use with cocaine-dependent outpatients (N = 122), those 
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with a comorbid PTSD diagnosis had a greater number of axis I disorders (e.g., Major 
Depression)on the Structured Clinical Interview for DSM-III-R (SCID), axis II disorders 
(e.g., greater proportion of obsessive-compulsive personality disorder) on the SCID, Beck 
Depression Inventory scores (M = 15.8 for those with PTSD versus M = 7.3 for those 
without comorbid PTSD), 17-item Hamilton Depression scale scores (M = 12.4 versus M 
= 5.5), the Brief Symptom Inventory total score (M = 1.14 versus M = 0.37), the Beck 
Anxiety Inventory scores (M = 12.5 versus M = 4.2), and the Inventory of Interpersonal 
Problems score (M = 1.47 versus M = 0.98) (Najavits, Gastfriend, et al., 1998).  Other 
research indicates that compared with non-PTSD SUD female patients, SUD-PTSD 
female patients have a greater likelihood of meeting diagnostic criteria for major 
depressive disorder, panic disorder, bipolar disorder, and Cluster B personality disorders 
(Brown, Stout, & Mueller, 1999).   
Ouimette, Wolfe, and Chrestman (1996) compared characteristics of women (N = 
47) diagnosed with PTSD and alcohol abuse (i.e., PTSD-AA; n = 12), women with 
PTSD-only (n = 13), and women with neither alcohol abuse nor PTSD (i.e., controls; n = 
22), using a sample of women who had served overseas during the Vietnam era (1964-
1975).  Findings revealed that the PTSD-AA group, compared to the PTSD-only group 
and the control group, reported more childhood sexual abuse experiences, a greater 
number of traumatic events, and a more severe history of adult sexual assault.  In 
addition, sexual victimization specific to wartime differentiated those with PTSD-AA 
from the other groups, suggesting that sexual victimization occurring during wartime may 
have played a role in later alcohol abuse (22 years old was the mean age of entry into 
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military, while 26 years old was the average age of onset for alcohol abuse/dependence).  
Furthermore, women with PTSD-AA suffered from a greater range of symptoms (e.g., 
borderline traits, dissociation, and more severe PTSD symptomatology) than women with 
PTSD-only or controls.  Women with PTSD-AA also reported poorer affect regulation, 
impulsivity, and difficulties with interpersonal relationships (Ouimette, Wolfe, & 
Chrestman, 1996).   
Numerous studies have indicated that women with co-occurring PTSD-related 
symptomatology and SUD have worse compliance with aftercare for SUD treatment and 
more addiction-related problems (e.g., physical appearance, criminal behavior, etc.) 
(Brady, Killeen, Saladin, Dansky, & Becker, 1994; Gutierres & Van Puymbroeck, 2006; 
Najavits, Weiss, & Shaw, 1999).   The proposed study expects to find higher levels of 
psychological distress and increased rates of symptoms of depression among female SUD 
residential patients who have experienced trauma compared to those without trauma, 
emphasizing the importance of prevention and intervention efforts.   
Importance of Addressing Trauma in SUD Treatment 
Comorbid PTSD is correlated with low rates of treatment engagement and a high 
incidence of treatment drop-out among both women and men with SUDs (Brown, 
Recupero & Stout, 1995; Ouimette, Finney & Moos, 1999).  These individuals tend to 
have less effective coping strategies, including fewer expected benefits from quitting, 
greater use of emotional discharge coping (e.g., yelling, risk taking), and more positive 
expectancies about substance use (Ouimette, Ahrens, Moos & Finney, 1997).  Chronic 
substance use may reduce emotional reactions related to traumatic experiences, thus 
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reinforcing the potential of future drug use (Stasiewicz & Maisto, 1993).  Negative 
emotions related to trauma may increase substance craving, and can contribute to 
generally poorer treatment outcomes (Coffey, et al., 2002).  Thus, studies suggest that 
treatments that diminish negative emotions related to trauma may also decrease craving, 
which could contribute to better treatment outcomes (Coffey, et al., 2002).   
Since untreated PTSD symptomatology may contribute to poorer treatment 
outcomes, the association between trauma and SUDs may be relevant for SUD treatment 
(Brady, Killeen, Saladin, Dansky, & Becker, 1994).  Improving severe drug abuse may 
uncover PTSD-related symptoms and heighten subjective distress, and untreated PTSD-
related symptoms may contribute to relapse to substance use (Clark, et al., 2001).  While 
some untreated PTSD symptoms improve (e.g., global measures of intensity/frequency) 
with cessation of drug use, other symptoms of PTSD (e.g., intrusive thoughts, 
nightmares, flashbacks) are unlikely to improve with SUD treatment alone (Clark, et al., 
2001; Dansky, Brady, & Saladin, 1998).  Additionally, research indicates that while 
remission from PTSD is associated with better SUD outcomes, remission from SUD is 
not associated with improved PTSD outcomes (Ouimette, Brown, & Najavits, 1998), 
indicating that in SUD treatment settings, approaches that specifically target trauma may 
be necessary if PTSD symptoms are expected to improve (Dansky, Brady, & Saladin, 
1998).  
While significant experiential avoidance is present in both PTSD and SUDs 
(Morrisey, et al., 2005), patients with both problems are likely to get substance abuse 
services or mental health services, but not both (Batten & Hayes, 2005).  Experiential 
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avoidance is defined as purposeful, deliberate attempts to change the frequency or form 
of selective private events, such as unwanted thoughts, images, memories, emotions, and 
bodily sensations, or the circumstances in which they occur (Zettle, Petersen, Hocker, & 
Provines, 2007).  In many SUD treatment settings, trauma and PTSD are rarely assessed 
and trauma-focused interventions are not part of treatment services (Ouimette, Moos, & 
Finney, 2003; Reynolds, et al., 2005).  The patients‘ own numbing and embarrassment 
about trauma may work against trauma symptom recognition (Brown, Recupero, Stout, 
1995).  Also, both drug use and drug withdrawal may intensify, imitate, or complicate 
symptoms of PTSD, making identification more challenging (Reynolds, et al., 2005).   
Historically, there has been an ongoing debate regarding which problem to treat 
first; PTSD or SUDs.  Among SUD treatment providers, the general consensus had been 
that addressing trauma during the early phase of SUD recovery may ―open Pandora‘s 
box‖ and derail SUD treatment improvement (Hien, Cohen, Miele, Litt, Capstick, 2004).  
There is now evidence, however, to suggest that trauma should be treated, even in the 
earliest stages of SUD treatment.  While requiring drug use cessation before trauma 
treatment may aid in the implementation of current trauma interventions, it may do so at a 
cost for those with dual problems (Batten & Hayes, 2005).  Research strongly advocates 
that counselors address both problems simultaneously, with evidence that such an 
approach actually contributes to addiction recovery, rather than derailing SUD patients 
from abstinence (Brady, Dansky, Back, Foa, Carroll, 2001; Hien, et al., 2004; Najavits, 
2006).   
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Despite such research findings, many drug treatment programs continue to ignore 
trauma and PTSD, suggesting that more education and training are needed.  The proposed 
study expects that a brief intervention, which addresses traumatic/stressful experiences 
among women in SUD treatment, may improve treatment outcomes, such as post-
traumatic symptom severity, health symptoms, depressive symptoms, drug cravings, and 
psychological distress related to the emotional experience.  In addition, if effective, the 
proposed intervention requires little training and minimal costs, making it readily 
transferable from research to clinical practice   
Treatment for patients with co-occurring SUD and PTSD symptomatology is an 
important issue, not only because of the frequency and severity of co-occurring SUD and 
PTSD, but also because treatments traditionally used for treating one of these problems 
may be inadequate to treat the combination of both problems.  For instance, 
benzodiazepines, which are commonly used for the treatment of anxiety disorders, are 
commonly contraindicated for women who are prone to addiction (Najavits, Weiss, & 
Shaw, 1997).  On the other hand, twelve-step self-help groups such as Alcoholics 
Anonymous (AA), which are often effective for individuals with SUDs, may be less 
applicable for women with comorbid PTSD-SUD, particularly early in their recovery 
because the groups: often focus on the past (which is contraindicated in many trauma-
focused treatments); are frequently attended by both males and females; and require 
individuals to share their stories publicly as they ―surrender to a higher power‖ (Najavits, 
et al., 1997).   
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Issues of treatment for women with co-occurring SUD and PTSD are heightened 
by clinical observations revealing that these women have a propensity for inducing 
uneasy alliances, a powerful negative countertransference by therapists, numerous crises, 
and are often labeled with a ―poor prognosis‖ (Najavits, et al., 1997).  The proposed 
study expects that a brief intervention, which requires little training and minimal costs 
and addresses traumatic/stressful experiences among women in SUD treatment, may 
improve treatment outcomes and distress related to the emotional experience. 
Assessing Trauma in SUD Treatment  
While there is overwhelming empirical evidence suggesting significant 
comorbidity of SUD and PTSD, unfortunately SUD treatment providers frequently fail to 
notice trauma and PTSD in their patients (Coffey, Schumacher, Brimo, & Brady, 2005).  
Treatment providers should be mindful that women do not readily recognize trauma or 
victimization as adults or children during intake interviews (Gutierres & Van 
Puymbroeck, 2006).  In addition, the timing of assessments (i.e., when reliable and valid 
information is most likely to be obtained) and methods for assessment (e.g., interviews 
versus questionnaires) are important issues to consider (Read, Bollinger, & Sharkansky, 
2003).   
A key issue in the assessment procedures is that any drug use by individuals could 
mask or diminish PTSD symptomatology.  Thus, PTSD assessment should not be done 
while the person is actively using drugs and/or alcohol.  Assessment of trauma and PTSD 
symptoms should preferably occur after withdrawal symptoms have abated (Read, 
Bollinger, & Sharkansky, 2003; Saladin, Brady, Dansky, & Kilpatrick, 1995).  Since 
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memory difficulties can be related with drug withdrawal, assessment of traumatic 
experiences and associated consequences will be more dependable following 
detoxification.  Also, providers should be aware that withdrawal symptoms from drugs 
and alcohol (e.g., nightmares, increased anxiety, and difficulty sleeping) may overlap 
with symptoms found in PTSD, which can easily skew estimated rates of PTSD, and 
make it more challenging to reliably identify co-occurring conditions (Brown, et al., 
1999; Read, et al., 2003).  Thus, treatment providers should check for potentially separate 
and complicating problems, because without such diagnostic assessments and consequent 
treatment recommendations and referrals, PTSD and trauma patients may not get 
sufficient care, which could eventually lead to poorer treatment outcomes (Brown, et al., 
1999). 
There are several self-report instruments that provide an effective and time-
efficient method of assessing trauma and PTSD.  These instruments evaluate traumatic 
exposure and incorporate DSM-IV criteria, and can be given in a variety of research and 
clinical settings.  Self report questionnaires offering the most promise in facilitating the 
recognition of trauma and PTSD, specifically with respect to co-occurring SUD-PTSD 
populations include: the PTSD Symptom Scale-Self Report (PSS-SR; Foa, Riggs, Dancu, 
& Rothbaum, 1993), the PTSD Checklist (Weathers, Litz, Herman, Huska, & Keane, 
1993), and Posttraumatic Stress Diagnostic Scale (PDS; Foa, 1996). All of these 
measures have strong psychometric properties with both treatment-seeking and 
community samples (Read, Bollinger, & Sharkansky, 2003). 
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 Expressive Writing  
Expressive Writing and Disclosure  
Accumulating evidence over the past two decades suggests that disclosure of 
traumatic and emotional experiences through expressive writing has widespread physical 
and mental health benefits (Pennebaker & Seagal, 1999).  The typical laboratory writing 
technique involves randomly assigning individuals to one of two or more writing groups.  
All groups are instructed to write about assigned topics for 15 to 20 minutes a day over 
three to five consecutive days, and the writing is typically done with no feedback given.  
Individuals who are assigned to the expressive writing group are asked to write about the 
most traumatic or stressful event of their lives, while those who are in the control 
conditions are generally instructed to write about superficial topics, such as how they use 
their time (Pennebaker, 1997; Sloan & Marx, 2004).   
Beneficial effects related to writing about emotional experiences have been shown 
in areas as varied as health, achievement, and general well-being (Slatcher & Pennebaker, 
2006).  For instance, studies using Pennebaker‘s expressive writing paradigm reveal that 
writing about a highly stressful or traumatic event is associated with improved immune 
functioning (Booth, Petrie, & Pennebaker, 1997), a decrease in health center and doctor‘s 
visits (Pennebaker, Kiecolt-Glaser, & Glaser, 1988; Pennebaker, Mayne, & Francis, 
1997), fewer missed days of work or school (Francis & Pennebaker, 1992), decreases in 
sympathetic nervous system activity (McGuire, Greenberg, & Gervirtz, 2005; 
Pennebaker, Barger, & Tiebout, 1989; Pennebaker, Hughes, & O'Heeron, 1987), and a 
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reduction in the degree to which the experience is distressing or painful (Lepore & 
Smyth, 2002).   
Pennebaker and Beall (1986) found that expressive writing (writing about an 
earlier trauma) was related with short-term heightened physiological arousal and long-
term decreases in health problems among undergraduate students (N = 46).  In an 
examination of autonomic effects of expressive writing in people with elevated blood 
pressure (N = 38), systolic and diastolic blood pressure was significantly decreased 
among those in the expressive writing group as compared to the control writing group 
(McGuire, Greenberg, & Gevirtz, 2005).  McGuire and colleagues (2005) also found a 
significant interaction revealing that the very low frequency of heart rate variability rose 
over time in the control writing group only, indicating a possible buffering effect in 
expressive writing.  In another study, university employees (N = 41) who wrote about a 
traumatic experience showed a significant reduction in absentee rates from work (28.6% 
reduction) while employees who wrote about a non-traumatic topic showed an increase in 
absentee rates (48.5% increase) during the month of writing relative to the eight months 
prior to the experiment (Francis & Pennebaker, 1992).  In a study looking at the effects of 
expressive writing on PTSD symptoms and depression among women who have endured 
intimate partner violence (N = 47), those who were depressed showed a significantly 
greater drop in depression if they were in the traumatic disclosure (experimental) writing 
group as compared to the neutral topic (control) group (Koopman, et al., 2005).   
In a meta-analysis of expressive writing studies (N = 13 studies that used 
randomized experiments) the included data from over 800 participants, Smyth (1998) 
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found a 23% symptom improvement in the traumatic disclosure writing condition over 
the control writing condition, which indicates a moderate effect size (d = .47; r = .23, p 
<.0001).  This effect size is comparable or larger than those found in other psychological, 
educational, or behavioral interventions (Pennebaker & Chung, in press; Smyth, 1998).  
For instance, in a review of approximately 500 studies on psychotherapy, Smith and 
Glass (1977) found an average 32% greater improvement among those receiving 
psychotherapy compared to those who did not.   
Another recent meta-analysis examining experimental disclosure and its 
moderators, using 146 randomized studies (48% unpublished), found experimental 
disclosure to be effective, with an average effect size of r =.075 (Frattaroli, 2006).  
Results showed that individuals in expressive writing conditions revealed improved 
psychological health, physiological functioning, disease specific outcomes and illness 
behaviors, and general functioning (Frattaroli, 2006).  
Thus, expressive writings‘ efficacy, efficiency (15-20 minutes per session over 
three to seven consecutive days, compared to psychotherapy, which usually occurs for an 
hour per week over several months or years), and cost-effectiveness (the cost of a 
notebook), suggest that writing as a means for disclosing traumatic experiences may be a 
powerful adjunct to traditional alcohol and drug treatment, particularly in SUD treatment 
settings that do not routinely screen for trauma and PTSD and therefore, do not 
specifically focus on such issues during treatment. 
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Expressive Writing with Different Populations 
Early studies of expressive writing were conducted mainly with university 
students (Frattaroli, 2006).  However, more recently, the effects of written disclosure 
have been studied in more varied samples.  Studies using non-student samples, for 
example, found that expressive writing was beneficial in decreasing trips to the infirmary 
among male prison inmates (Richards, Beal, Seagal, & Pennebaker, 2000), and in helping 
recently unemployed professionals find employment faster (Spera, Buhrfeind, & 
Pennebaker, 1994).   
Studies suggest the disclosure paradigm is as beneficial for maximum security 
prisoners with 6
th
 grade educations as it is for senior professionals with advanced degrees 
(Richards, et al., 2000; Spera, et al., 1994), and yields positive outcomes regardless of 
ethnicity or native language among college students (Pennebaker & Chung, in press).  
For example, Richards and colleagues (2000) examined expressive writing on illness 
behavior among psychiatric prison inmates (N = 98) and found a significant decrease in 
infirmary visits among sex offenders in the trauma writing condition.  The prisoners had 
a sixth grade level education or higher, with a mean of 11.9 years of education 
completed.  In an examination of expressive writing and coping with job loss among 
recently unemployed professionals (N = 63) who had an average tenure of 20 years of 
employment with advanced degrees, the expressive writing condition (writing about their 
deepest thoughts and feelings surrounding job loss) was associated with being 
reemployed more quickly than both the non-traumatic writing condition and the non-
writing condition (Spera, et al., 1994).  Expressive writing appeared to influence the 
 38 
person‘s attitude with regard to their old job and finding new employment.  Interestingly, 
while the study was originally slated to last one year, at four months authors discovered 
that those in the expressive writing condition were being rehired at a significantly higher 
rate than those in either control conditions, and therefore terminated the study early in 
order to invite the people from the control conditions to receive the expressive writing 
condition. 
The expressive writing paradigm has also recently been expanded to include 
individuals with medical ailments, such as rheumatoid arthritis, asthma, migraines 
(Smyth, Stone, Hurewitz, & Kaell, 1999), chronic pelvic pain (Norman, Lumley, Dooley, 
& Diamond, 2004), and breast cancer (Low, Stanton, & Danoff-burg, 2006).  Patients in 
the written disclosure conditions show clinically relevant improvements in 
symptomatology and health status relative to patients who do not write (Smyth, et al., 
1999).   
For instance, a study of patients (N = 107) with asthma (n = 49) or rheumatoid 
arthritis (n = 49) found that asthma patients who were in the experimental condition (n = 
39) and wrote about the most stressful event of their lives for 3 consecutive days, showed 
improvements in lung function at four month follow-up, whereas asthma patients who 
were in the control group (n = 22), and wrote about emotionally neutral topics for 3 
consecutive days, showed no change at four month follow-up (Smyth, et al., 1999).  A 
similar intervention was done with rheumatoid arthritis patients, and Smyth and 
colleagues (1999) found that those in the experimental group (n = 32) showed 
improvements in overall disease activity at the four month follow-up, whereas control 
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group patients (n = 19) did not change.  Smyth and colleagues (1999) reported that after 
combining all patients, almost half (47.1%) of experimental patients showed clinically 
relevant improvement, whereas less than one quarter (24.3%) of control patients showed 
improvement. 
Likewise, in an examination of expressive writing with breast cancer patients (N = 
60), written disclosure was found to produce significantly reduced physical symptoms 
and medical appointments for cancer-related morbidities among breast cancer patients 
relative to patients in a fact-writing control condition (Stanton, Danoff-Burg, & 
Sworowski, 2002).  In another study looking at women with chronic pain (N = 48), 
Norman and colleagues (2004) found that compared with control writing, women in the 
disclosure writing group had less disability, particularly when the women had higher 
ambivalence scores at baseline. 
Mechanisms through which Expressive Writing Works  
While expressive writing is shown to be beneficial, the underlying mechanisms 
through which it works are not well understood (Sloan & Marx, 2004).  A few of the 
most widely used explanatory mechanisms that have been suggested to account for the 
observed benefits include the inhibition theory (Pennebaker, 1989), cognitive processing 
theory (Pennebaker, 1993), and self-regulation theory (Greenberg, et al., 1996; Lepore, 
Greenberg, Bruno, & Smyth, 2002).   
Inhibition Theory.  The inhibition theory argues that inhibition of feelings and 
thoughts concerning an upsetting experience is detrimental; therefore, disclosure of 
feelings and thoughts can diminish threats and enhance various psychological and 
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physical health outcomes (Pennebaker, Barger, & Tiebout, 1989; Pennebaker, Hughes, & 
O'Heeron, 1987).  Inhibition may partially mediate the association between the 
psychological threat and illness.  Specifically, physiological work of inhibition (i.e., 
physiological exhaustion), the interruption of cognitive processing prohibiting resolution, 
and the heightened social isolation of not disclosing significant matters to others, can all 
add to stress and illness (Pennebaker & Keough, 1999).  
Inhibition of the traumas can emerge through dreams, ruminations, intrusive 
memories, and related behaviors and cognitive symptoms.  By inhibiting, people may not 
interpret the event into a language that would allow for understanding and assimilation of 
the experience (Pennebaker, 1997; Pennebaker & Keough, 1999).  Yet, since it is not 
always necessary for traumatic experiences to be previously undisclosed, studies suggests 
an inhibition explanation may not be fully adequate to explain benefits of expressive 
writing (Greenberg & Stone, 1992).   
Cognitive Processing Theory.  The cognitive processing theory (Pennebaker, 
1993) suggests that confronting a traumatic event through expressive writing may help to 
organize, assimilate, give meaning, or incorporate the upsetting event into one‘s self-
schema (Pennebaker & Beall, 1986).  Thus, expressive writing may allow individuals to 
gain insight into what happened.  Merely expressing trauma is not sufficient, but rather 
health benefits appear to involve translating events into language (Pennebaker, 1997).  
Three linguistic factors: increased positive emotion words, a moderate number of 
negative emotion words, and, most important, an increased use of causation words (e.g., 
because, cause, effect) and insight words (e.g., consider, know) over the course of 
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writing, appear to be significantly related with benefits and improved health (Pennebaker, 
1993; Pennebaker & Keough, 1999; Pennebaker, et al., 1997).  Also, individuals who 
start with poorly organized accounts and progress to coherent stories by the last day of 
writing benefit significantly from expressive writing (Pennebaker, 1997).  The proposed 
study will examine written essay content via a computerized text-analysis program that 
calculates words of multiple categories (Linguistic Inquiry and Word Count [LIWC]; 
Pennebaker, Francis, & Booth, 2001). 
Self-Regulation Theory.  The self-regulation or emotion-regulation theory posits 
that self-regulation may mediate the beneficial effects of expressive writing (Lepore, 
Greenberg, Bruno & Smyth, 2002).  Lepore and colleagues (2002) suggest that 
experimental disclosure may help by allowing people to observe themselves expressing 
and controlling their emotions.  Thus, written disclosure may offer a new or stronger 
sense of self-efficacy or self-regulation for the individual (Frattaroli, 2006).   
After emotional disclosure, one may feel that their traumatic experience(s), 
stressors, or challenges are more controllable, which may help diminish negative affect 
and contribute to other improvements in overall well-being (Lepore, Greenberg, et al., 
2002).  Written disclosure through expressive writing can help an individual comprehend 
or acknowledge his or her response to the event, make sense of the event, explore sources 
of emotions, clarify goals, and habituate to the traumatic event through written exposure.   
In accordance with the above theories of expressive writing, many trauma 
theorists maintain that the recovery process from trauma entails special processing of 
traumatic memories: skills to organize, articulate, and streamline the traumatic event has 
 42 
been recommended as markers to recovery.  Observations made in clinical settings 
indicate that trauma narratives told by individuals with chronic PTSD are characterized 
by incomplete sentences and remarks that reveal confusion (Foa & Street, 2001).  
Furthermore, research on trauma and PTSD suggest that the extent to which the 
individual (a) organizes and articulates the traumatic memory; (b) is emotionally engaged 
with the traumatic memory; and (c) upholds a balanced view about the world and self 
influences whether that individual will improve or develop chronic disturbances (Foa & 
Street, 2001). 
  
Statement of the Problem and Hypotheses 
Women with SUDs are identified as high risk for co-occurring traumatic stress 
exposure.  As many as 80% of women needing treatment for drug problems report 
lifetime histories of physical and/or sexual assault (Hien, Cohen, & Campbell, 2005), and 
many display Posttraumatic Stress Disorder (PTSD) symptomatology (e.g., Brown, Stout, 
& Mueller, 1999).  In these settings, 55% to 99% of women report at least one lifetime 
trauma (Najavits, Weiss, & Shaw, 1997).  Trauma and addiction comorbidity studies 
consistently reveal these women are likely to have poorer health and increased disability, 
more severe clinical profiles, and worse treatment adherence, than those without 
traumatic experiences or PTSD (Najavits, 2006).  
The proposed investigation seeks to examine whether Pennebaker‘s expressive 
writing paradigm is beneficial for these women, who are currently undergoing residential 
SUD treatment.  The expressive writing paradigm includes writing about an assigned 
topic for 15-20 minute sessions per day over three to five consecutive days.  Past studies 
have demonstrated the efficacy of expressive writing with significant reductions in 
distress (Smyth, 1998), and improved physical (e.g., Pennebaker, et al., 1997) and 
psychological health (Lepore & Smyth, 2002).  Its usefulness as an intervention for SUD 
populations is unknown, however.  Historically, trauma has not been incorporated into 
SUD treatment programs; however, studies indicate that addressing trauma during SUD 
treatment may improve treatment (e.g., Hien, et al., 2004).   
 44 
The proposed investigation seeks to examine whether Pennebaker‘s expressive 
writing paradigm is beneficial for women currently undergoing SUD treatment.  If 
expressive writing improves outcomes for women with SUDs, these findings would 
support its use as a brief, cost effective, adjunct to current SUD treatment. 
The specific aims of this study are to: 1) investigate physical and mental health 
problems, as well as the relationships between PTSD and/or trauma and physical and 
mental health problems; 2) compare outcomes for a treatment-based sample of substance 
abuse/dependent women assigned to either a expressive writing condition (emotional 
topic) or a control writing condition (neutral topic); and 3) examine the influence of the 
writing task on both immediate and longer-term levels of psychological distress. 
Based on previous literature, it was hypothesized that: 1) women with co-morbid 
PTSD and/or significant trauma will have more severe psychological and physical health 
problems at baseline; 2) at two weeks and one month following the 4-day writing 
intervention, participants randomized to the expressive writing condition will show 
greater reductions in post-traumatic symptom severity, health symptoms, psychological 
distress, and depressive symptoms, than participants randomized to the control writing 
condition; and that 3) women randomized to the expressive writing group would show 
higher levels of immediate distress (measured immediately after each writing session) 
and lower levels of longer-term distress (measured at two weeks and one month post-
baseline assessment) relative to those in the control group.  
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Methods 
 
Objectives of Proposed Study 
The primary goal of this study is to test whether Pennebaker‘s expressive writing 
paradigm is a useful therapeutic adjunct for women in residential treatment for SUDs.  
This study was approved by Virginia Commonwealth University‘s Institutional 
Review Board under ―Expressive Writing as a Therapeutic Process for Drug Dependent 
Women,‖ protocol number HM10881. 
Study Site  
The study occurred at Rubicon, Inc., a large nonprofit organization located in 
Richmond, Virginia, that provides residential treatment services to women with SUDs.  
Specific services at Rubicon include individual and group counseling, motivational 
enhancement therapy groups, and case management for such needs as housing, 
transportation, and childcare.  
Experimental Overview 
 Women enrolled in residential substance abuse treatment at Rubicon, Inc. were 
invited to participate in a randomized clinical trial comparing expressive writing to a 
control group.  The study involved baseline assessment, followed by 20 minute daily 
writing sessions that took place over four consecutive days.  For the experimental 
(expressive writing) group, writing sessions focused on life experiences while the control 
group participants wrote about neutral topics.  Follow-up assessments occurred at 2 
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weeks and 1month post-intervention and focused on psychological functioning, drug 
craving and other relevant domains of psychosocial functioning.  
At baseline, participants who provided informed consent completed 
questionnaires assessing demographic information, post-traumatic severity, distress, 
craving, depressive, drug use, and health symptoms.  Group assignment occurred prior to 
the first writing session, with participants randomly assigned to either the experimental or 
control writing groups.  Those in the experimental (expressive writing) group were asked 
during writing sessions 1-4, to write about personal traumatic/stressful experiences, while 
those in the control writing group were asked to write on neutral topics (e.g., what they 
ate on the previous day, what they did since waking up yesterday).  At 2 week and 1 
month post-intervention visits, participants were asked to complete a follow-up packet 
consisting of the same questionnaires administered at baseline (except the demographic 
questionnaire and the SCID), as well as a specific follow-up questionnaire that included 
questions about what participants thought of the writing, while also acting as a 
manipulation check to find out if participants heard about the other writing instructions.   
Participants 
Participants were recruited in-person by the lead investigator or another 
experimenter, who was unaffiliated with Rubicon‘s treatment.  Women were approached 
within the first few days of residential treatment and asked to volunteer for a study in 
which they will be asked to write stories related to their life (Sloan & Marx, 2004).   
Recruitment.  Recruitment occurred at the Rubicon, Inc., a residential women‘s 
substance abuse treatment facility from June 17, 2007 through November 06, 2008.  
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Program admission records were used to identify women who had recently been admitted 
for residential care.  Once the principal investigator (PI) or other research staff members 
identified a new admission, the woman was asked to report to the Staff on Duty (SOD) 
office.  Care was taken to minimize disruption in the woman‘s standard program 
activities.  When the patient arrived at the SOD office, she was asked about her projected 
length of stay at Rubicon (which typically varies from 30 to 60 days, but could be 
extended if warranted).  If the patient had been approved to receive at least 60 days of 
residential care, the PI or other research staff would use the following recruitment script 
(approved by VCU‘s IRB): 
I would like to let you know about a research study being conducted by 
researchers from Virginia Commonwealth University (VCU) that involves women being 
treated for substance abuse.  The purpose of this research is to study women’s reactions 
to journal writing.  It will take about 10 minutes of your time to hear more about it.  If 
you qualify, you could earn up to $50.00 in gift cards for your time and effort for 
participating in the study. Your decision to be in the study or not will not impact your 
treatment here at Rubicon.  The study is totally separate, and your decision to participate 
in this research is completely voluntary.  
If the patient was interested in participating, informed consent was obtained and 
the participant was provided with a copy of the consent document, while the original 
consent form was retained by the research team and filed in a locked drawer.   
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Inclusion criteria:  To be included in the study, a woman had to:  1) Be at least 18 
years of age; 2) Meet DSM-IV criteria for a SUD; and 3) Have approval for 60 days of 
residential treatment at Rubicon.   
Exclusion criteria:  Individuals were ineligible for study participation if they:  1) 
Had an acute or chronic mental disorder that would make them unable to follow study 
protocol procedures (e.g., chronic psychosis, mental retardation, current suicidality); or 2) 
Had problems that would prevent them from completing the writing intervention, the 
baseline assessment, or the follow-up assessment (e.g., illiteracy).  To assess for literacy, 
participant will be asked to read a part of the consent form aloud.  
 Risk for Recruitment Bias.  It should be noted that from 10/17/08 through 
07/16/08, another study by other members of our research team was recruiting subjects 
concurrent with the present study.  The other research project focused on women with 
alcohol problems and investigators targeted women approved for 30 as well as 60 days of 
treatment.  To determine the impact this might have on sample representativeness, the 
number of women referred to the other project was tracked throughout the recruitment 
period.  Specifically, n = 17 women were recommended for the other study and excluded 
from the present research.  These n = 17 women were found to be eligible for the present 
study, but were considered ineligible because they were already enrolled in the other 
project (which began before the present study started to enroll participants).   
Sample Size.  A power analysis using 0.80 power, an alpha level of 0.05, and a 
written disclosure effect size of 0.23, indicates that a minimum of 30 participants per 
condition would be sufficient to find a medium effect, requiring a minimum total sample 
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size of 60 women (Cohen, et al., 2003) to achieve primary study outcomes.  An 
additional 90 women, which will increase the sample size to 150 participants, were 
recruited and included in order to allow for subsequent analyses for such things as patient 
race, degree of substance abuse, and trauma severity.  The present study was initially 
funded as a pilot study through the VCU Institute for Women‘s Health.  Subsequently, a 
NIDA R36 Dissertation grant was awarded, which allowed the PI to increase sample size 
for the clinical trial.  The increased sample size also provides enough power in order to 
examine subgroups within the sample for future analyses. Attrition rates in previous 
written disclosure studies range from 4% (Sloan & Marx, 2004b) to 13% (Greenberg & 
Stone, 1992).  Assuming a 13% attrition rate, participants were recruited individually, 
and the protocol was administered individually until 150 women had been recruited for 
the study.   
Study Procedures   
Baseline Assessment 
On the initial day of the study, participants were informed that the study would 
involve a baseline assessment (25 minutes), followed by four writing sessions over 
consecutive days, a two week follow-up assessment, and finally a one-month follow-up 
assessment, and that they could receive up to $50 in gift cards if they participated in all 
phases of the research.  The baseline assessment consisted of six measures (see below) 
and was administered in a confidential setting by the lead investigator or another 
experimenter.  Study participants were assured that the data they provided would not be 
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shared with Rubicon clinical/treatment staff and that they would receive a $5 gift card 
after finishing the assessment battery.  
Measures at Baseline.  Participants were asked to provide basic demographic and 
personal information. The following measures were also administered:   
The Posttraumatic Stress Diagnostic Scale (PDS; Foa, et al., 1997), a 49-item 
self-report measure, aids in PTSD diagnosis and symptom severity, with items that 
parallel to DSM-IV criteria (APA, 1994). The PDS has high test-retest reliability (r = 
.83), high internal consistency (r = .92), and high convergent validity (Foa, 1996).   
The Brief Symptom Inventory (BSI; Derogatis, 1983), a 53-item inventory, is a 
shortened version of the SCL-90 (Symptom Check List-90) that assesses nine symptoms 
of distress and provides three global distress indices. The BSI has high scale-by-scale 
correlations with the SCL-90, high internal consistency (Cronbach's alpha: 0.71-0.85), 
convergent, discriminant, test retest reliability (r = .68–.91), and construct validity 
(Derogatis & Melisaratos, 1983).  BSI indices include the following dimensions of 
distress: Somatization (SOM; distress arising from perception of bodily dysfunction); 
Obsessive-Compulsive (O-C; thoughts and actions experienced as unremitting and 
irresistible [e.g. checking and re-checking actions]); Interpersonal Sensitivity (I-S; 
feelings of personal inadequacy and inferiority); Depression (DEP; symptoms of the 
clinical depression); ‖ Anxiety (ANX; symptoms associated anxiety); Hostility (HOS; 
thoughts, feelings, and actions of hostile behavior:); Phobic Anxiety (PHOB; symptoms 
of phobic anxiety or agoraphobia [e.g. fears towards public places, open spaces, travel, 
etc.]); Paranoid Ideation (PAR; characteristics including projection, suspiciousness, 
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hostility, fear of loss of autonomy, and centrality); Psychoticism (PSY; mildly alien 
lifestyle at one extreme to floridly psychotic status at the other); and General Severity 
Index (GSI; depth of symptomatic distress experienced by the individual) (Derogatis & 
Melisaratos, 1983).   
The Center for Epidemiological Studies-Depression Scale (CES-D; Radloff, 
1977), a 20-item self-report measure that assesses symptoms of depression, has high 
internal consistency for a psychiatric population (α. = .90).   
The Pennebaker Inventory of Limbic Languidness (PILL; Pennebaker, 1982) is a 
54-item scale that assesses the frequency of common physical symptoms and sensations.  
PILL has shown Chronbach‘s alphas ranging from .88 to .91, and 2-month test-retest 
reliabilities ranging from .79 to .83.   
The Structured Clinical Interview for DSM-IV-TR - Alcohol and Substance Use 
Disorders Module (SCID; First, et al., 2002) is a diagnostic interview assessing SUD 
diagnosis, including alcohol and other drugs. The SCID has demonstrated good validity 
and high interrater reliability for SUDs (Coffey, et al., 2002). The SCID was 
administered at baseline assessment only, and is and includes an interview component.  
The Brief Substance Craving Scale (BSCS; Somoza, 1999) is a 12-item self-
report instrument assessing intensity, frequency, and length of craving over a 24 hour 
period for substances of abuse on a five-point Likert scale.  Each of the three items 
related to the ―intensity,‖ ―frequency,‖ and ―length‖ of craving during the prior 24 hours 
is answered on a 0-4 scale which was summed to yield a ―total score‖ ranging from 0-12 
(Somoza, et al., 1999).   
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 All measures are included in Appendix B, unless copyrighted. 
Expressive Writing Intervention 
Those who qualified for the study were randomized to either one of two 
conditions: control writing condition (neutral topic) or an expressive writing condition 
(emotional topic) using a random numbers table.  
Writing Conditions:  To be consistent with typical writing paradigm studies (Pennebaker 
& Beall, 1986; Greenberg & Stone, 1992), participants were asked to write over four 
consecutive days for 20 minutes per session. Writing instructions were adapted from 
instructions developed by Pennebaker (1997).  All writing instructions were read out loud 
to the participant upon meeting with the investigator before each writing session.  A copy 
of the exact writing instructions read by the investigator was also attached to the front 
flap of each journal so that the participant could re-read the instructions at any time. 
Expressive Writing group.  The standard writing instructions for those in the 
expressive writing condition adhered to the instructions used by Pennebaker & Chung (in 
press): 
Over the next four days, I want you to write about your deepest emotions and thoughts 
about the most traumatic experience in your life. In your writing, I’d like you to really let 
go and explore your very deepest emotions and thoughts.  You might tie this trauma to 
your childhood, your relationship with others, including your parents, lovers, friends, or 
relatives.  You may also link this event to your past, present, or your future, or to who you 
have been, who you would like to be, or who you are now.  You may write about the same 
general issues or experiences on all days of writing or on different topics each day.  Not 
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everyone has had a single trauma but all of us have had major conflicts or stressors in 
our lives and you can write about them as well.  All of your writing will be completely 
confidential.  Don’t worry about spelling, sentence structure, or grammar.  The only rule 
is that once you begin writing, continue to do so until your time is up.   
Control Writing group.  Those in the control condition were asked to write about 
an assigned topic on each of the four writing days (description of what they had eaten 
since yesterday during the first session, how they spent their day during the second 
session, etc.).  An example of the standard writing instructions for those in the control 
condition is as follows: 
Over the next four days, I will give you a writing assignment.  In today’s writing, I would 
like you to describe what you have eaten since yesterday morning.  I am not interested in 
your emotions or opinions.  Rather I want you to write about specific objects or events in 
detail without discussing your thoughts or feelings.  Feel free to be as detailed as 
possible.  Again, I want you to describe exactly what you have eaten up until coming to 
this experiment. For example, you might describe the texture, the color, an estimate of 
calories and fat, how big the portions were, what meal you were eating, etc. The most 
important thing in your writing, however, is for you to describe what you ate since 
yesterday as accurately as possible. 
Writing Session One.  The day after baseline assessments were completed, 
participants were individually administered the appropriate writing instructions by the 
lead investigator or another experimenter.  Writing instructions for each condition and 
session were based on the protocols used by Pennebaker, et al. (1988) and Sloan & Marx 
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(2004), and are outlined in Appendix A.  Participants were asked not to discuss the study 
or the writing instructions they received with anybody while residing at Rubicon.  After 
receiving the writing instructions from first experimenter, participants were introduced to 
a second experimenter (trained graduate student), who remained blind to the condition 
throughout the study.  The second experimenter handed participants an immediate 
version of the Positive and Negative Affect Schedule (PANAS; Watson, et al., 1988), 
which participants completed prior to being given a blank note pad.  Participants were 
instructed to locate a comfortable place where they would not be disturbed (e.g., their 
room), and were asked to write about their assigned topic area for the next 20 minutes 
(i.e., until the experimenter has returned).  After returning (20 min later), they were 
handed the PANAS, and the Essay Evaluation Measure (EEM) (described below) 
assessing the degree to which they revealed their emotions, etc., in the essay (Pennebaker 
& Beall, 1986).  Essays, which were marked by participant ID number, were then 
dropped into a cardboard box along with their responses to the PANAS and EEM.  
Finally, participants were instructed to meet with the first experimenter at a prearranged 
time on the following day for the next writing session.  They then received their $5 gift 
card for participating in the writing session.     
Writing Sessions Two and Three.  All participants were greeted for each session 
by the first experimenter, who reiterated the same writing instructions as in session one. 
As in session one, the second experimenter instructed participants to complete the 
PANAS before writing for 20 minutes, but remained blind to study group assignment.    
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The PANAS and EEM were administered after each writing session.  Participants were 
again asked to return for the next session on the following day. 
Writing Session Four.  Procedures were the same as those described for sessions 
two and three. Upon completing the activities described above, however, participants 
were given an appointment card for the two week follow-up.   
Measures at Writing Sessions.  Participants were asked to complete an immediate 
version of the Positive and Negative Affect Scale (PANAS; Watson, et al., 1988), both 
pre- and post-writing assignment.  The PANAS assesses negative affect (NA) and 
positive affect (PA), using 10 items for NA and 10 items for PA.  Scales are shown to 
have high internal consistency reliabilities, ranging from .84 to .87 for NA and from .86 
to .90 for PA, and are unchanged by the time point used.   
The Essay Evaluation Measure (EEM; Greenberg & Stone, 1992) was 
administered at each writing session and served as manipulation check after each writing 
session.  To test the intended effects of trauma writing, the EEM assesses participants‘ 
report, along separate 7-point scales, ranging from 1 (not at all) to 7 (a great deal), the 
extent to which their essays were meaningful, personal, and revealing, and the extent they 
had actually talked to others, had wanted to talk to others, and had actively held back 
from talking to others about the subject(s) in the essays.  Comparisons were made 
between the groups to determine if the experimental group identified their writing as 
more meaningful, personal, and revealing of their emotions than those in the control 
group (Lepore, 1997).   
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Follow-Up Assessments 
Two-Week Follow-Up.  Two weeks after the first writing session, participants 
were asked to complete a follow-up packet, including each questionnaire that was 
administered prior to writing except the demographic questionnaire and the SCID, but 
with a follow-up questionnaire added.  The assessments were administered by the 
experimenter who remained blind to study condition and subjects received $10 for their 
time and effort.  Participants were then scheduled for a one month follow up and given an 
appointment card.  
One Month Follow-Up.  As in prior studies (Sloan & Marx, 2004; Brown & 
Heimberg, 2001), one month after writing session four, participants were asked to 
complete a follow-up packet, including each questionnaire that was administered prior to 
writing except the demographic questionnaire and the SCID.  The assessments were 
administered by the experimenter who remained blind to study condition and subjects 
received $15 for their time and effort. 
Measures at Follow-Ups.  As previously stated, all measures from the baseline 
assessment, were included, with the exception of the demographic questionnaire and the 
SCID.  However, during follow-ups, participants completed a PANAS (which was not 
completed during baseline assessments), as well as a Follow-Up Questionnaire. 
Follow-up Questionnaire.  A follow-up questionnaire was administered at the end 
of the two week and one month assessment batteries.  The questionnaire included both 
close-ended and open-ended questions addressing whether the participants found the 
writing helpful, whether she talked about the subject matter from her essays with anyone 
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during her treatment at Rubicon, whether she continued using the same writing 
instructions after the study was complete, etc.  Items also included questions about 
whether or not the participant heard about the writing instructions from other clients at 
Rubicon, and whether she told other clients at Rubicon about the writing instructions she 
had been given.  
Dependent Measures 
Dependent measures included change scores on the following measures: 1) 
trauma symptom severity, distress, depressive symptom severity, bodily symptoms 
frequency, and drug craving (baseline; two-week follow-up; one-month follow-up); and 
2) mood rating forms (before and after each writing session and follow-up).  
More specifically, trauma symptom severity was measured using the total sum 
scores of items assessing re-experiencing, arousal, and avoidance symptoms from the 
PDS.  These three categories include some of the criteria used when diagnosing a current 
DSM-IV PTSD diagnosis.  Distress levels were measured using raw scores from the BSI 
for each of the nine indices, as well as the Global Servity Index.  Depressive symptom 
severity included the total sum score from the CES-D, while clinically elevated 
depression scores were assessed using a CES-D cut-off score of 16.  Bodily symptoms 
and sensations (i.e., physical symptoms and health problems) were assessed using the 
total sum score from items on the PILL.  Drug craving was measured using the sum of 
intensity, frequency, and craving scores in the BSCS.  Finally, mood ratings (i.e., distress 
or negative affect) were calculated using the sum of Negative Affect items from the 
PANAS. 
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Compensation 
Experimental and control writing group participants had the opportunity to earn 
equal amounts of compensation for their time and efforts.  All study participants received 
a $5 gift card for completing the baseline assessment and a $5 gift card for completing 
each of the four writing sessions ($20 total).  In addition, they received a $10 gift card for 
completing the two-week follow-up session and $15 for completing the one-month 
follow-up assessment.  Thus, a woman who participated in all elements of the 
intervention and follow-ups would earn the equivalent of a $50 gift card to a local 
merchant for her time and effort.  Gift cards (e.g., Dollar General) were selected because 
cash payment is not allowed by this study site and they have been described as 
―reinforcing‖ by women who participated in previous studies at Rubicon.   
 
Critical Methodological Issues 
Several methodological issues needed to be addressed during the design of this 
project.  They are listed below, along with a summary of the factors that contributed to 
the decisions made.   
Minimization of cross-contamination: While cross-contamination is an inherent 
limitation in studies that utilize a residential treatment setting, the proposed study 
identified several ways to minimize and measure the impact of possible diffusion of 
treatment.  First, participants were asked to keep confidential all written materials, and 
not to share the instructions given (See Appendix).  In addition, the essay evaluation 
 59 
measure (EEM) served as a fidelity measure after each writing session.  Also, written 
essay content was reviewed to determine whether instructions were followed in essays.  
Finally, at the two week and one month follow-ups, participants were asked whether they 
shared or received information about writing instructions with other Rubicon participants.  
Sample representativeness:  The proposed study evaluated the expressive writing 
paradigm with female SUD patients in a residential treatment facility.  While residential 
treatment is no longer the normative modality of care in the US, it was determined that 
residential care was the most appropriate setting.  Safety and methodology factors 
contributed to the decision.  Specifically, this is the first study to examine expressive 
writing as a therapeutic adjunct in a female SUD population.  The benefits of utilizing a 
residential program for participant safety and collection of follow-up data far outweighed 
potential limits placed on generalizability to more traditional outpatient settings.  At 
Rubicon, residential program staff were available 24-hours a day and could intervene 
immediately should any adverse events (e.g., psychiatric distress) occur during the 
intervention or follow up periods.   
Female SUD patients are an appropriate target population for a traumatic 
disclosure intervention, as the majority has experienced at least one event of an intensity 
level sufficient to potentially elicit PTSD, and SUD patients who experienced PTSD 
symptomatology report greater rates of medical problems, psychological symptoms, 
addiction severity, and PTSD-related symptomatology than non-traumatized patients 
(e.g., Najavits, et al., 1997). A diagnosis of PTSD, however, is not an inclusion criterion 
since previous expressive writing studies show the intervention is beneficial for 
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individuals with a history of trauma, regardless of whether they meet PTSD diagnostic 
criteria (Pennebaker, et al., 1988).   
Controlling for educational, linguistic, or cultural effects:  Studies suggest the 
disclosure paradigm is as beneficial for maximum security prisoners with 6
th
 grade 
educations as it is for senior professionals with advanced degrees (Spera, et al, 1994; 
Richards, et al., 2000), and yields positive outcomes regardless of ethnicity or native 
language among college students (Pennebaker & Chung, in press).  Thus, the expressive 
writing paradigm, with the traditional instructions used in most expressive writing 
studies, was determined to be suitable for use with the present population.   
Ethical issues in elicitation of traumatic memories:  While decades of research 
suggests that eliciting traumatic memories through writing over several brief sessions 
may cause an initial rise in negative emotion, trauma disclosure has long-term 
psychological and physical health benefits (Sloan et al., 2004a; Pennebaker et al., 1986); 
and, no harm to participants has been encountered as a result of expressive writing 
studies.  The rise in negative mood immediately after trauma writing has been found to be 
transient, and at follow-up, participants generally report that they feel happier than they 
did before writing (Pennebaker, et al., 1990).  Therefore, negative mood scores were 
evaluated prior to, and immediately after, writing sessions in order to determine that 
eliciting traumatic memories through writing did not produce undue harm, and to further 
confirm that increases in distress would be short-lived. 
Minimization of study attrition at follow-up:  In order to limit attrition, a number 
of steps were taken.  First, participants were fully informed of the tasks involved and 
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encouraged not to participate if they cannot reasonably write for four consecutive days. 
Second, only those who were approved for 60 days of residential treatment at Rubicon 
were eligible to participate in this study, thus increasing the chance of obtaining one-
month follow-up data.  (It should be noted that time approved for residential stay is 
determined by the referral source that is paying for the client, not by severity of drug 
problem.)  Third, participants received gift cards for completing each session of the study 
($5 for baseline assessment, $5 for each of the four writing sessions), and received 
increased compensation for completing the two week follow-up assessment ($10 gift 
card) and the one month follow-up assessment ($15 gift card).  A choice of gift cards, 
phone cards and/or bus tickets has been well received in prior studies at this treatment 
site.  Also, the one-month follow-up time frame was used for outcome measures to 
maximize retention rates.   
It should be noted, however, that the one component of study methods was 
revised after the first n = 22 participants had completed the study.  Specifically, 
investigators determined that the residential program, which provided the context for the 
randomized clinical trial, provided a host of standard services.  Therefore, it was 
important to look at the immediate impact of expressive writing on psychosocial 
functioning.  Also, some participants were leaving treatment prematurely (against 
medical advice, AMA).  Thus, IRB approval was obtained to add a 2-week follow-up 
assessment to the study protocol, allowing the investigators to collect short-term outcome 
data from a larger pool of study participants.    
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Expectancy effects:  In order to reduce unintentional expectancy effects and 
investigator bias, one experimenter administered baseline assessments and all writing 
instructions, while a second experimenter, who remained blind to the assigned writing 
conditions, administered mood rating measures, EEMs, and follow-up assessments.   
Design of the control condition:  The control group writing topics were selected 
based on a thorough review of previous expressive writing studies conducted with similar 
populations.  While a neutral topic with this population is difficult, studies conducted 
with prison inmates, for example, found that having participants write about how they use 
their time served as a successful control writing topic (Richards, et al., 2000).  Another 
topic is to have participants write in detail about their eating habits (e.g., writing exactly 
what they have eaten in the past week, etc.) (J. W. Pennebaker, Personal Communication, 
January 08, 2007). 
 Stratifying issues:  In the original pilot study funded by VCU‘s Institute for 
Women‘s Health, stratification was not warranted with the small sample size.  While 
ideally, stratified randomization could have been done with a larger sample size (i.e., 
with the addition of the R36 NIDA-funded Dissertation grant), since the study was 
already ongoing, procedures for randomization were left unchanged.  Stratified 
randomization prohibits imbalance between treatment groups for identified factors that 
influence prognosis or treatment responsiveness (Kernan, Viscoli, Makuch, Brass, & 
Horwitz, 1999).  A decision was made to continue the randomization procedures as they 
were, and to check on baseline differences and control for them in subsequent analyses.   
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Data Analysis Plan 
Descriptive statistics were computed to examine subject characteristics.  T-test 
and chi-square analyses were run to examine sample representativeness and potential 
generalizability.  These analyses also examined whether there were significant 
differences between treatment conditions at baseline.  T-test and chi-squares further 
examined whether there were group differences on demographic variables.  Any 
identified differences were statistically controlled for in subsequent analyses.   
Descriptive Comparisons.  T-tests and chi-squares examined rates of trauma, physical 
health problems, distress, depression, and drug preference in a sample of drug dependent 
women. 
Hypothesis One.  The first hypothesis predicted that women with co-morbid PTSD and/or 
significant trauma would have more severe psychological and physical health problems 
than those without co-morbid trauma.   To test this hypothesis, t-tests for continuous 
variables and chi-square analyses for categorical variables measured whether trauma 
symptom severity and/or PTSD was associated with more significant physical health and 
psychological problems (i.e., levels of distress, depression, physical symptoms and 
sensations, current Substance Use Disorder) upon admittance to residential SUD 
treatment.   
Hypothesis Two.  The second hypothesis predicted that relative to control writing 
participants, individuals assigned to the expressive writing condition would show greater 
improvements in psychological and physical health at follow-up.  While it was expected 
that there would be improvements across the board for both writing conditions as a 
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function of being in residential treatment, it was further hypothesized that there would be 
an interaction, such that trauma writing participants would show greater reductions in 
post-traumatic symptom severity, health symptoms, and depressive symptoms than 
participants who wrote about a control topic.  To evaluate whether there were differences 
between the expressive writing group and control writing group over time, the 
interactions between group and time for each dependent variable was examined.  
Significant interactions were followed up with a test of simple main effects to determine 
the nature of the interaction. 
Short-term effects (measured at the two week follow-up) were tested by 
examining between-group differences over time using a 2 Group (writing topic: 
experimental; control) by 2 Time (baseline; two week follow-up) repeated-measures 
analysis of variance (ANOVA) separately for each outcome measure (PDS, BSI, CES-D, 
and PILL).  Longer-term effects (measured at one month follow-up) were examined 
using a 2 Group (writing topic: experimental; control) by 2 Time (baseline; one month 
follow-up) repeated-measures analysis of variance (ANOVA) in order to examine 
differences over time between groups at one month follow-up on the PDS, BSI, CES-D, 
and PILL.  Interactions effects and post-hoc analyses were examined.  Follow-up contrast 
tests were conducted to examine between-group differences.  If a dependent variable was 
found to be significantly different between groups at baseline, those baseline scores were 
controlled for using a univariate analysis of covariance (ANCOVA). 
 Intent-to-treat analyses were also conducted to include all participants who 
enrolled in the study.  These analyses used the entire sample of n = 149 randomized 
 65 
participants (82 expressive writing participants and 67 control writing participants), 
replacing missing outcome data for the ‗non-completers‘ by carrying forward each 
participant‘s previous score (e.g. baseline value or two-week value).    
Hypothesis Three.  The third hypothesis stated that women randomized to the expressive 
writing group would show higher levels of immediate distress (measured immediately 
after each writing session) and lower levels of longer-term distress (measured at two 
weeks and one month post-baseline assessment) relative to those in the control group.  
Furthermore, while those in the expressive writing group were hypothesized to show 
higher levels of immediate distress, it was predicted that these increases would be short-
lived, revealing no difference in pre-writing scores the following day.  It was expected 
that groups would not differ in negative affect before writing, but that immediately after 
writing, the expressive writing group would show more negative affect than the control 
writing group; however, at follow-up this increase in negative affect was expected to 
decrease, and the expressive writing group would show less negative affect than the 
control group (Schwartz & Drotar, 2004). 
A 2 Group (Writing Topic: Expressive Writing; Control Writing) by 2 Time (pre- 
and post-writing session) by 4 Session (Writing 1; Writing 2; Writing 3; Writing 4) 
repeated measures multivariate analysis of variance (MANOVA) examined the 
interaction between pre-post writing and condition at each of the four sessions.   
A repeated measures 2 Condition (writing topic: expressive writing; control 
writing) by 3 Time (Pre-writing; two week post-writing; one month post-writing) 
ANOVA was conducted in order to examine whether expressive writing participants 
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experienced greater improvements in short-term and longer-term distress levels relative 
to those in the control group.   
Fidelity Monitoring.  T-tests compared the expressive writing group with the control 
writing group on items of the EEM to evaluate participants‘ self reports of their response 
to the experimental and control manipulation.  Because the participants completed the 
EEM four times (after each 20 minute writing period), the mean of the four days for each 
participant was used in analyses.  The experimental group was expected to report their 
essays as more meaningful, personal, revealing, and more likely to be discussed with 
others, that they have the more desire to discuss the topics of their essays with others, and 
that they more actively held back from talking with others (Schwartz & Drotar, 2004).   
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Results 
Demographics 
Table 1 summarizes demographic characteristics for the entire sample and 
separately for participants randomized to the expressive writing and control writing 
conditions.  Overall, women were in their mid-30‘s (mean 36.3 years, SD = 8.6); had less 
than a high school education (mean 11.2 years, SD = 1.8); were single/never married 
(92.7%); and over 2/3rds (70%) identified their race as African-American.  Comparisons 
for women randomized to the expressive writing and control writing conditions were 
made using independent t-tests for continuous measures and chi-square analyses for 
categorical measures.  Only one group difference was found, with expressive writing 
group women being approximately 3 years older than control group women, t (148) = 
2.3, p < .05.   
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Table 1 
Participant Characteristics: Expressive Writing (n = 82) and Control Writing (n = 67)  
  
 Expressive 
Writing 
% or M (SD) 
Control 
Writing 
% or M (SD) 
Total Sample  
% or M (SD) 
Age (years) 37.7 (8.7) 34.6 (8.2)* 36.6 (8.3) 
Education (last grade completed) 11.5 (1.6) 10.9 (2.0) 11.2 (1.8) 
Marital Status    
       Married 4.4% 9.8% 7.3% 
       Single/Never Married 95.6% 90.2% 92.7% 
Race    
     % Caucasian 25.6% 23.5% 24.7% 
     % African-American  69.5% 70.6% 70.0% 
     % Hispanic  1.2% 0.0% 0.7% 
     % Other 3.7% 5.9% 4.7% 
*p < .05 
 
Data Analysis 
Outliers and Tests of Normality.  Frequency distributions and univariate statistics were 
examined for evidence of non-normality and outliers.  Using centered leverages, 
externally studentized residuals, DFFITS, DFBETAS, and by visually inspecting the data 
plotted on histograms, outliers were detected on the BSI and the negative affect scale of 
the PANAS measure.  Specifically, over the course of the three assessments (baseline, 
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two-week follow-up, one month follow-up) outliers were detected on four of the ten 
indices of the Brief Symptom Inventory (z scores > 3.29), including: n = 1 on the PHOB 
index at baseline (z = 3.6), n = 1 on the PHOB index at two weeks (z = 3.3), and n = 2 on 
the PHOB index at one month (z = 3.7 and 3.4); n = 1 on the HOS at two weeks (z = 3.5) 
and n = 1 on the HOS at one month (z = 3.8); n = 1 on the SOM at baseline (z = 3.6), and 
n = 1 on the SOM at one month (z = 3.8); and n = 2 on the ANX at one month (z = 3.7 
and 3.5).  The Positive and Negative Affect Scale (PANAS) also revealed outliers at 
various timepoints, including: n = 1 at one month (z = 3.6); n = 3 at two week follow-up 
(z = 5.3, 3.8, 3.6); n = 1 at writing session four, time one (z = 3.6); n = 1 at writing 
session three, time two (z = 3.35); n = 2 at writing session three, time one (z = 3.86, 
3.59); n = 3 at writing session two, time one (z = 3.85, 3.7, 3.59); n = 2 at writing session 
one, time one (z = 3.64, 3.38).  Outliers found for any Brief Symptom Inventory raw 
scores or any of the negative affect items from the PANAS were changed to represent 3 
standard deviations above the mean (Cohen, Cohen, West, & Aiken, 2003).   
Kolmogorov-Smirnov and Shapiro-Wilk statistics were used to test for normality 
of the data. Skewness and kurtosis were also examined by dividing kurtosis and skewness 
by their standard errors.  These tests confirmed that study data were normally distributed. 
 
Success of Randomization.   
While n = 150 women provided informed consent, one participant was never 
randomized to a writing condition because she became ill after completing the baseline 
assessment.   Out of n = 149 participants who completed randomization, n = 82 (55%) 
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were randomized to the expressive writing condition and n = 67 (45%) were randomized 
to the control writing condition.  
Analyses were run to examine whether there were significant baseline differences 
between women randomized to the experimental and control groups.  No significant 
differences were found in number of reported traumatic events, trauma symptom severity, 
or a PTSD diagnosis (p > .05).  Also, no significant differences were found for frequency 
of common physical symptoms and sensations (physical health problems) or type(s) of 
substance use disorders (all p > .05).  Furthermore, the two groups did not differ in 
intensity, frequency, or length of craving (as measured by the BSCS) for their most 
significant current substance use problem(s) over the past 24 hours (all p > .05).   
Comparison of BSI baseline scores for women randomized to either the 
expressive writing or control writing group found only one significant group difference 
across all nine BSI indices.  Specifically, women randomized to the expressive writing 
condition had significantly higher Anxiety dimension scores at baseline compared with 
those in the control writing condition (M = 1.3 [SD = 1.1] versus M = 0.8 [SD = 0.8], 
respectively), t(148) = 3.0, p < .005.   
Similarly, women in the expressive writing condition obtained higher CES-D 
depression scores than those randomized to the control writing condition (M = 25.2 [SD = 
12.0] versus M = 21.1 [SD = 10.9], respectively), t(148) = 2.2, p < .05.  A chi-square 
revealed that there were no significant differences in the number of participants with a 
clinically elevated depression level (i.e. ≥ 16 cutoff on the CESD) between conditions 
(76.8% versus 67.2%), p > .05.   
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Screened for Eligibility 
(n = 290) 
Excluded (n = 141) 
  Ineligible (n = 139) 
  Refused   (n = 2) 
Randomized 
(n = 149) 
Randomized to Expressive 
Writing Condition 
(n = 82) 
 
Randomized to Control Writing 
Condition 
(n = 67) 
Writing Sessions Completed: 
One session (n = 82) 
Two Sessions (n = 80) 
Three Sessions (n = 77) 
Four Sessions (n = 77) 
Non-Completers of All Sessions (n = 5) 
Writing Sessions Completed: 
One session (n = 67) 
Two Sessions (n = 65) 
Three Sessions (n = 64) 
Four Sessions (n = 64) 
Non-Completers of All Sessions (n = 5) 
 
Completed 2-Week Follow-up (n = 74) 
Non-Completers of 2-Wk Follow-Up 
(n = 3) 
 
 
 
Completed 2-Week Follow-up (n= 58) 
Non-Completers of 2-Wk Follow-Up 
(n = 6) 
 
Completed 1-Month Follow-up  
(n = 70) 
Non-Completers of 1-Mth Follow-up  
(n = 4) 
 
 
Completed 1-Month Follow-up  
(n = 50) 
Non-Completers of 1-Mth Follow-up  
(n = 8) 
 
 Figure 1.  Flow chart of participants through study 
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Attrition Differential 
 Writing Session Attrition.  As depicted in Figure 1, rates of compliance with the 
intervention and control conditions were quite high, with (n = 149) participants 
completing at least one writing session and almost all of the participants (n = 145; 97.3%) 
completing more than one writing session.  Specifically, 97.6% of expressive writing 
participants (n = 80) and 97.0% of control writing participants (n = 65) completed at least 
two writing sessions.  There were n = 4 (n = 2 [2.4%] expressive writing and n = 2 
[3.0%] control writing) participants who did not complete more than one writing session. 
Of these participants, n = 1 expressive writing participant left Rubicon against medical 
advice (AMA), and the remaining n = 3 participants did not complete more than one 
writing session due to medical reasons (e.g., left the facility for the day to go to the 
doctor, came down with the flu, etc.), which precluded these participants from 
completing four writing sessions over consecutive days.   
A majority of the participants (n = 141; 94.6%) completed more than two writing 
sessions (n = 77 expressive writing participants [93.9%] and n = 64 control writing 
participants [95.5%]).  There were n = 4 (n = 3 expressive writing [2.5%] and n = 1 
control writing [1.5%]) participants who did not complete more than two writing 
sessions.  Reasons for not completing more than two writing sessions were similar to 
reasons stated above (n =1 expressive writing participant left Rubicon AMA, while the  
remaining n = 3 participants did not complete more than two writing sessions due to 
medical reasons precluding them from writing over four consecutive days).   
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The remaining n = 141 (94.6%) participants completed all four writing sessions.  
T-tests and chi square analyses revealed no significant differences between those who 
completed all writing sessions versus those who did not complete all writing sessions, p > 
.05.  Thus, there appear to be no systematic differences in completer versus non-
completer rates for the four consecutive writing sessions.  In addition, participants who 
did not complete the study did so for reasons outside of the study (e.g. left the facility 
AMA or became sick and/or had to go to the doctor/hospital during the first week of 
residential treatment, and therefore could not complete all writing sessions on four 
consecutive days).  A priori we had made the decision to continue to follow these women 
to identify factors that contributed to participant discontinuation in the study. 
 
Two-Week Follow-Up Attrition.  A total of n = 132 (n = 74 expressive writing 
[90.2%] and n = 58 control writing [86.6%]) participants were categorized as 
‗completers‘ for all four writing sessions as well as the two-week follow-up assessment.  
Since a two week follow-up assessment was added into the study procedure after the first 
n = 22 participants were already enrolled, a mean substitution by condition analysis was 
calculated for those who completed a one month follow-up assessment (n = 16).  Since 
the remaining n = 8 participants (out of the first n = 22) did not complete the one month 
follow-up assessments, they were not included in completer analyses.  There were n = 9 
participants that completed all four writing sessions, but did not complete the two-week 
follow-up.  Reasons for not completing the two week follow-up included: leaving 
Rubicon AMA (n = 7; [n = 5 control writing participants, n = 2 expressive writing 
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participants), due to medical reasons precluding them from being present at Rubicon (n = 
1; n = 1 control writing participant), or due to being discharged earlier than the expected 
60 days, for reasons like a death in the family or a change in admittance length (n = 1; n = 
1 expressive writing participant). 
 Attrition for the two-week follow-up was examined for all participants on all 
dependent variables.  T-tests and chi-square showed no significant differences between 
‗completers‘ versus ‗non-completers‘ on any of the dependent variables, p > .05.  When 
examining attrition at two-week follow-up for the expressive writing participants only, t-
tests and chi-square analyses revealed no significant differences between ‗completers‘ 
versus ‗non-completers‘ on any of the dependent variables, p > .05.   
 However, when examining two-week follow-up attrition for the control writing 
participants only, an independent samples t-test revealed that women who did not 
complete the two-week follow-up were significantly more depressed at baseline  
compared with women who completed the two-week follow-up (M = 28.0 [SD = 6.8] 
versus M = 20.0 [SD = 11.1], respectively), t (65) = 2.1, p < .05.  In addition, a 2 x 2 chi-
square analysis indicated that, among women randomized to the control group, those that 
did not complete the two-week follow-up were significantly more likely to have had 
clinically elevated depression levels (i.e. ≥ 16 cutoff on the CESD) at baseline compared 
with those who completed the two-week follow-up (100 % versus 62.1%, respectively), 
2 (2, N = 67) = 5.1, p < .05.  There were no other significant differences between 
completers versus non-completers at the two-week follow-up among the control writing 
participants on any other dependent variables, p > .05.  
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One Month Follow-up Attrition. A total of n = 120 (80.5%) (n = 70  [85.4%] 
expressive writing and n = 50 [74.6%] control writing) participants completed all phases 
of study procedures, including writing sessions as well as the two-week and one-month 
follow-up assessments.    Reasons for not completing the one month follow-up included: 
leaving Rubicon AMA (n = 6 [n = 4 control writing participants, n = 2 expressive writing 
participants), due to incarceration (n = 2; n = 2 control writing participants), or due to 
being discharged earlier than the expected 60 days, for reasons like a death in the family 
or a change in admittance length (n = 4 [n = 2 expressive writing participants, n = 2 
control writing participants]). 
Attrition for the one month follow-up assessment was examined for all 
participants on all dependent variables.  There were no significant differences between 
‗completers‘ versus ‗non-completers‘ at one month follow-up on any of the dependent 
variables, p > .05.  An examination of attrition at one-month follow-up for the expressive 
writing participants only, revealed no significant differences between ‗completers‘ and 
‗non-completers‘ on any of the dependent variables, p > .05.  An examination of attrition 
at one-month follow-up for the control writing participants only, also revealed no 
significant differences between ‗completers‘ versus ‗non-completers‘ on any dependent 
variables, p > .05.   
  
Descriptive Analyses  
Trauma and PTSD among Residential SUD Women.  As shown in Table 2, the 
majority of study participants (96%) reported at least one lifetime trauma at baseline, 
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with a mean of 3.7 (SD = 2.3) different types of trauma (e.g., sexual assault, non-sexual 
assault, serious accident, etc.).  Over half (54.4%) of the women met diagnostic criteria 
for current (past month) PTSD.  In addition, SUD women with co-morbid PTSD reported 
significantly more types of trauma than SUD women without PTSD (M = 4.6 [2.3] versus 
M = 2.8 [1.8], respectively), t (147) = 5.1, p < .005.  Furthermore, 92.6% of women with 
co-morbid PTSD reported two or more types of trauma versus 73.5% of those without 
PTSD reporting more than two different types of traumas, 2 (2, N = 149) = 9.9, p < .005. 
Table 2 
Trauma and PTSD: Expressive Writing (n = 82) and Control Writing (n = 67)  
  
 Expressive Writing 
%  
Control Writing 
%  
Total Sample  
% 
At least One Trauma 96.3% (n = 79) 95.5% (n = 64) 96.0%(n=143) 
Mean Number of Different  
Types of Trauma Events 
 
        PTSD diagnosis  
        (n = 81) 
 
        No PTSD diagnosis 
         (n = 68)  
 
     3.8 (SD = 2.2) 
 
4.6 (SD = 2.2) 
2.8 (SD = 1.8) 
3.6 (SD = 2.4) 
 
4.5 (SD = 2.6) 
2.8 (SD = 1.8) 
3.7 (SD=2.3) 
 
4.6 (SD = 2.3) 
2.8 (SD = 1.8) 
PTSD Diagnosis 58.5% (n = 48) 49.3% (n = 33) 54.4% (n=81) 
No PTSD Diagnosis 41.5% (n =34) 50.7% (n =34) 45.6% (n =68) 
Trauma Symptom Severity    
       All Residents 21.3 (SD=13.4) 17.5 (SD=12.4) 19.5(SD=13.1) 
       PTSD Diagnosis Only  
       (n =81) 
 
29.2 (SD=10.3) 26.4 (SD=9.0) 28.1 (SD=9.8) 
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When lifetime trauma exposure was characterized for the sample, the most 
prevalent traumas included: Imprisonment (55.7%); Sexual contact when younger than 
18 with someone 5 or more years older (45.0%); Sexual assault by a stranger (41.6%); 
Sexual assault by a family member or someone the participant knew (40.3%); Non-sexual 
assault by someone the participant knew (39.6%); Non-sexual assault by a stranger 
(34.2%); Serious accident or fire (34.9%); Other traumatic event (28.2%); Natural 
disaster (24.2%); Life threatening illness (20.1%); Torture (10.1%); and Military combat 
or a war zone (7.0%).   
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Table 3 
Different Types of Trauma Events: Expressive Writing (n=82) and Control Writing 
(n=67)  
 Expressive Writing 
%  
Control Writing 
%  
Total Sample  
% 
Serious Accident or Fire  34.1% (n=28) 35.8% (n=24) 34.9% (n=52) 
Natural Disaster  26.8% (n=22) 20.9% (n=14) 24.2% (n=36) 
Non-sexual Assault by 
Someone You Know 
34.1% (n=29) 35.8% (n=30) 39.6% (n=59) 
Non-sexual Assault by a 
Stranger  
39.0% (n=32) 28.4% (n=19) 34.2% (n =51) 
Sexual Assault by a Family 
Member or Someone You 
Know  
36.6% (n=30) 44.8% (n=30) 40.3% (n =60) 
Sexual Assault by a Stranger  46.3% (n=38) 35.8% (n=24) 41.6% (n = 62) 
Military Combat /War Zone  1.2% (n =1) 0.0% (n=0) 7.0% (n =1) 
Sexual Contact when Under 
18 years old by someone >5 
years older than You 
43.3% (n=38) 36.3% (n=29) 45.0% (n=67) 
Imprisonment 54.9% (n=45) 56.7% (n=38) 55.7% (n = 83) 
Torture 8.5% (n=7) 11.9% (n=8) 10.1% (n = 15) 
Life Threatening Illness 24.4% (n=20) 14.9% (n=10) 20.1% (n = 30) 
Other Traumatic Event 30.5% (n=25) 25.4% (n=17) 28.2% (n = 42) 
 
Various Indices of Distress among Residential SUD Women.  Mean scores for the 
nine primary symptom dimensions of the BSI are summarized for expressive and control 
writing conditions, as well as the total sample in Table 4.  Scores fell around the 50
th
 
percentile range (T scores around 50) compared with BSI‘s inpatient psychiatric female 
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norms (Derogatis, 1979), and, with the exception of the BSI Anxiety index, there were no 
other significant differences between the expressive writing and control groups at 
baseline.   
Table 4 
Brief Symptom Inventory: Expressive Writing (n = 82) and Control Writing (n = 67)  
  
Symptom 
Dimension/Construct 
Expressive Writing 
Raw Score 
Control Writing 
Raw Score 
Total Sample 
Raw Score 
Somatization 1.0 (SD = 0.8) 0.8 (SD = 0.8) 0.9 (SD = 0.8) 
Obsessive-Compulsive 1.6 (SD = 1.1) 1.4 (SD = 0.9) 1.5 (SD = 1.0) 
Interpersonal Sensitivity 1.2 (SD = 1.0) 1.0 (SD = 1.0) 1.1 (SD = 1.0) 
Depression 1.4  (SD = 1.0) 1.1 (SD = 1.0) 1.2 (SD = 1.0) 
Anxiety 1.3 (SD = 1.1) 0.8 (SD = 0.8) 1.0 (SD = 1.0)* 
Hostility 0.8 (SD = 0.8) 0.8 (SD = 0.7) 0.8 (SD = 0.8) 
Phobic Anxiety 0.8 (SD = 0.9) 0.7 (SD = 0.8) 0.8 (SD = 0.8) 
Paranoid Ideation 1.4 (SD = 0.9) 1.2 (SD = 0.9) 1.3 (SD = 0.9) 
Psychoticism 1.3 (SD = 1.0) 1.0 (SD = 0.8) 1.2 (SD = 0.9) 
General Severity Index 1.2 (SD = 0.8) 1.0 (SD = 0.7) 1.1 (SD = 0.7) 
*p < .05 
Levels of Depression and Common Physical Symptoms among Residential SUD 
Women. Almost three fourths of all participants (72.5%) obtained clinically elevated 
CES-D scores at baseline.  Women with clinically elevated depression had significantly 
greater physical health symptoms (as measured by the PILL) compared to women 
without clinically elevated depression (M = 122.2 [SD = 35.5] versus M = 101.0 [SD = 
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33.2], respectively), t (147) = 3.3, p < .005.  There were no differences between the two 
writing conditions in the percentage of elevated depression scores or in physical health 
symptoms at baseline.  Participants in the expressive writing condition, however, had 
significantly higher CES-D scores at baseline compared to those in the control writing 
condition (M = 25.2 [SD = 12.0] versus M = 21.1 [SD = 10.9], respectively), t(147) = 2.2, 
p < .05.  Baseline score differences were statistically controlled for in subsequent testing 
of core hypotheses.  
Table 5 
Center for Epidemiological Studies- Depression Scale (CES-D) and Pennebaker 
Inventory of Limbic Languidness (PILL) 
 Expressive Writing 
N = 82 
Control Writing 
N = 67 
Total Sample 
N = 149 
CES-D depression score 25.2 (SD=12.0)* 21.1 (SD=10.9) 23.3 (SD=11.7) 
CES-D Cutoff ≥ 16  76.8%  67.2% 72.5% 
PILL score 118.8 (SD=37.6) 113.5(SD=34.2) 116.4(SD=36.0) 
*p < .05 
  
 
Primary Drugs of Dependence among Residential SUD Women. As shown in 
Table 6, a large proportion of participants (80%) indicated cocaine as one of their 
primary drugs of dependence (as measured by the Alcohol and Substance Use Disorders 
Module of the SCID).  Over half (57%) met DSM-IV criteria for Substance Dependence 
(current) for more than one drug.   
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Table 6 
DSM-IV Substance Dependence diagnosis (current): Expressive Writing (n = 82) and 
Control Writing (n = 67)  
  
 Expressive Writing 
%  
Control Writing 
%  
Total Sample  
% 
     Alcohol 32.9% 23.9% 28.9% 
     Amphetamine/Stimulant  0.0% 1.5% 0.7% 
     Cannabis 11.0% 9.0% 10.1% 
     Cocaine 80.5% 83.6% 81.9% 
     Hallucinogen 1.2% 0.0% 0.7% 
     Inhalant 0.0% 0.0% 0.0% 
     Opioid 47.6% 41.8% 45.0% 
     Sedative 6.1% 4.5% 5.4% 
    More than One Drug 63.4% 49.3% 57.0% 
Note: The majority of participants met criteria for more than one class of drugs  
 
Brief Substance Craving Scale.  Mean Brief Substance Craving Scale scores for the two 
groups and total sample are shown in table 7.  An examination of participants‘ intensity, 
frequency, and length of craving for their drug(s) of choice over the past 24 hours at 
baseline appeared to be relatively low (M = 2.9).  Based on the low rates of craving, this 
measure was dropped from further analyses examining treatment outcomes. 
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Table 7 
Brief Substance Craving Scale: Expressive Writing (n =82) and Control Writing (n = 67)  
  
 Expressive Writing 
 
Control Writing 
 
Total Sample  
 
     Craving Scale (1
st
 Drug) 3.1 (SD=3.6) 2.7 (SD=3.2) 2.9 (SD = 3.4) 
     Craving Scale (2
nd
 Drug) 2.4 (SD=3.8) 2.1 (SD=3.3) 2.3 (SD=3.6) 
     Craving Scale (3
rd
 Drug) 1.1 (SD=3.2) 1.0 (SD=2.5) 1.0 (SD=2.9) 
 
Hypothesis One 
The first hypothesis stated that trauma symptom severity and/or PTSD would be 
associated with more significant psychological and physical health problems in upon 
admittance to residential SUD treatment.  
Trauma, PTSD, and Brief Symptom Inventory/Levels of Distress.  As shown in 
Table 8, all nine primary BSI symptom domain scores were significantly higher among 
those with a current PTSD diagnosis as compared with those without PTSD, p < .005. 
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Table 8 
Brief Symptom Inventory: PTSD Diagnosis (n = 81) and No PTSD Diagnosis (n = 69)  
  
Symptom 
Dimension/Construct 
PTSD 
Raw Score 
Mean (SD) 
No PTSD 
Raw Score 
Mean (SD) 
P 
Somatization  1.2 (SD = 0.9) 0.7 (SD = 0.7) p < .005 
Obsessive-Compulsive  1.8 (SD = 1.1) 1.2 (SD = 0.9) p < .005 
Interpersonal Sensitivity 1.4 (SD = 1.1) 0.8 (SD = 0.8) p < .005 
Depression     1.5 (SD=1.0) 0.9 (SD = 0.9) p < .005 
Anxiety 1.4 (SD = 1.0) 0.6 (SD = 0.7) p < .005 
Hostility 0.9 (SD = 0.9) 0.6 (SD = 0.6) p < .005 
Phobic Anxiety 1.0 (SD = 0.9) 0.4 (SD = 0.6) p < .005 
Paranoid Ideation 1.5 (SD = 1.0) 1.0 (SD = 0.7) p < .005 
Psychoticism 1.5 (SD = 1.0) 0.8 (SD = 0.7) p < .005 
Global Severity Index 1.4 (SD = 0.8) 0.8 (SD = 0.6) p < .005 
 
Trauma, PTSD, and Depression.   Consistent with hypothesis one, regardless of 
PTSD diagnosis, women with greater trauma symptom severity (i.e., re-experiencing, 
avoidance, arousal symptoms) reported more severe depression as measured by CES-D 
scores at baseline, r(149) = 7.3, p < .005.  Analyses further revealed that women with 
PTSD reported significantly greater depression levels as compared to those without 
PTSD (M = 26.4 [SD = 11.9] versus M = 19.7 [10.3], respectively), t(147) = 3.7, p < .005.  
In addition, women with clinically elevated depression levels (CES-D ≥ 16) reported 
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greater trauma symptom severity as compared with those without clinically elevated 
depression levels (M = 23.4 [SD = 12.6] versus M = 9.7 [SD = 7.9], respectively), t (147) 
= 6.5, p < .0005.  
  
Physical Symptoms/Health Problems and Trauma and PTSD.  Consistent with 
predictions, women with greater trauma symptom severity (i.e., re-experiencing, 
avoidance, arousal symptoms), regardless of whether or not they met criteria for current 
PTSD, reported more severe physical health problems as measured by the PILL at 
baseline, r (149) = 6.1, p < .0005.  Furthermore, women with a current DSM-IV PTSD 
diagnosis reported more severe physical health problems as compared with those without 
PTSD (M = 129.0 [SD= 35.3] versus M = 101.4 [SD = 31.1], respectively), t (147) = 5.0, 
p < .0005.   
 
Trauma, PTSD, SUD Type, and Drug Craving among Residential Drug 
Dependent Women.  Contrary to hypotheses, no relationship was found between trauma 
symptom severity and type(s) of SUDs, p > .05.  PTSD diagnosis also did not vary by 
type(s) of SUDs, p > .05.  Drug craving also did not vary as a function of PTSD 
diagnosis, p > .05.   
 
Hypothesis Two 
Another goal of the present study was to determine if women who engaged in 
expressive writing showed greater improvements in psychological and physical health at 
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follow-up.  It was expected that as a whole, there would be improvements across the 
board as a function of being in residential treatment.  However, it was hypothesized that 
there would be an interaction, such that trauma writing participants would show greater 
reductions in post-traumatic symptom severity, health symptoms, and depressive 
symptoms than participants who wrote about a neutral topic.  The mean baseline, two-
week, and one month follow-up scores for completers are listed in Table 11.  
 
Trauma Symptom Severity.   
Short-term Effects.  Consistent with hypothesis two, women in the expressive 
writing condition reported significantly greater reductions in levels of traumatic stress at 
the two week follow-up compared to women in the control writing condition, F (1, 130) 
= 5.6, p < .05, partial eta
2
 = .041.  Planned contrasts demonstrated that participants who 
were in the expressive writing condition reported significantly greater reductions in 
trauma symptom severity scores (from M = 21.2 [SD = 13.7] to M = 17.5 [SD = 12.4]), 
whereas those in the control writing condition did not (from M = 18.4 [SD = 12.6] to M = 
18.9 [SD = 11.8]), p < .05.  Intent-to-treat analyses also revealed significantly greater 
reductions in levels of traumatic stress among women in the expressive writing condition 
compared to women in the control writing condition at two week follow-up, F (1, 148) = 
5.8, p < .05.   
Follow-up tests showed significant decreases in trauma symptom severity, form 
baseline to two week follow-up scores, among expressive writing participants, F (1, 73) = 
8.7, p < .005, partial eta
2
 = .106.   Follow-up tests showed no significant decreases from 
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baseline to two week follow-up scores among control writing participants, F (1, 57) = 
0.2, p > .05.    
Longer-term Effects. There was no significant interaction effect on trauma 
symptom severity at the one-month follow-up, F (1, 119) = 0.7, p > .05.  Consistent with 
completer analyses, intent-to-treat analyses revealed no significant differences in 
reductions of trauma symptom severity, F (1, 147) = 0.6, p > .05.   
While women in the expressive writing condition did not differ from controls in 
reductions of trauma symptom severity at the one month follow-up, participants from 
both groups revealed significant improvements in trauma symptom severity scores at the 
one month follow-up.  A repeated measures ANOVA for the experimental group only 
revealed a significant decrease from baseline to one month follow-up scores, F (1, 70) = 
10.6, p < .005, partial eta
2
 = .133.   The control group only also showed a significant 
decrease from baseline to one month follow-up scores, F (1, 50) = 8.5, p < .006, partial 
eta
2
 = .148.       
 
Depression Levels.   
Short-term Effects.  Since CES-D depression scores were significantly different 
between groups at baseline, a univariate analysis of covariance (ANCOVA) controlled 
for baseline depression scores.  Contrary to hypotheses, there was no significant 
interaction effect on depression scores between the two writing groups at the two-week 
follow-up, F (1, 131) = 0.9, p > .05.  Similarly, intent-to-treat analyses revealed no 
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significant difference between groups at the two week follow-up, F (1, 148) = 1.4, p > 
.05.   
Longer-term Effects.  Consistent with short-term effects, there were no significant 
differences in decreases in depression scores between the two writing groups at the one 
month follow-up, F (2, 119) = 0.2, p> .05.  Intent to treat analyses were also non-
significant, F (2, 148) = 0.01, p > .05.  
However, participants from both groups revealed significant improvements in 
depression scores at the one month follow-up.  A repeated measures ANOVA for the 
experimental group only revealed significant improvements in depression  from baseline 
to one month follow-up, F (1, 70) = 16.8, p < .005, partial eta
2
 = .195.   A repeated 
measures ANOVA for the control group only also revealed a significant improvement 
from baseline to one month follow-up scores, F (1, 50) = 8.8, p < .006, partial eta
2
 = .152.       
 
Physical Health Problems.  
Short-term Effects.  Contrary to hypotheses, there were no significant interaction 
effects over time in the reduction of physical health symptoms and sensations between 
the two conditions, F (1, 129) = .01, p > .05.  Intent-to-treat analyses also revealed non-
significant findings, F (1, 147) = .02, p > .05.   
Longer-term Effects.  Consistent with short-term effects, there were no significant 
interaction effects in the reduction of physical health symptoms and sensations at the one 
month follow-up between conditions, F (1, 118) = 1.0, p > .05.  Intent-to-treat analyses at 
one month follow-up revealed similar non-significant findings, F (1, 147) = .8, p > .05.   
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A repeated measures ANOVA for the experimental group only revealed 
significant improvements in physical health symptoms and sensations from baseline to 
one month follow-up, F (1, 70) = 18.1, p < .005, partial eta
2
 = .208.   However, a repeated 
measures ANOVA for the control group only showed no significant improvements from 
baseline to one month follow-up scores, F (1, 50) = 2.8, p > .05.       
 
Table 9 
Effects of Expressive Writing versus Control Writing on Short-term and Longer-term 
Follow-Up 
Groups Expressive Writing Control Writing 
 Pre- 
Mean 
(SD) 
  
 
2 week-
posttest 
Mean 
(SD) 
1 month 
follow-up 
Mean 
(SD) 
Pre- 
Mean 
(SD) 
2 week-
posttest 
Mean 
(SD) 
1 month 
Follow-up 
Mean (SD) 
Trauma 
Symptom 
Severity 
21.2  
(13.7) 
17.5* 
(12.4) 
16.5  
(12.9) 
18.4  
(12.6) 
18.9  
(11.8) 
13.9  
(12.0) 
Depression 24.8  
(11.8) 
21.2  
(10.1) 
18.3  
(11.6) 
20.0  
(11.1) 
20.3  
(12.1) 
15.4  
(10.2) 
PILL 117.4 
(38.0) 
110.9 
(35.7) 
103.7 
(39.1) 
116.3 
(34.1) 
109.7 
(27.2) 
108.2 
(35.7) 
* p < .05 
 
Brief Symptom Inventory.  Having demonstrated that the groups were essentially 
similar and therefore comparable on all BSI indices, with the exception of the Anxiety 
BSI index, repeated measures analyses of variance (ANOVAs) examined baseline to two-
week follow-up differences between groups as well as baseline to one month follow-ups 
between the two groups.  A univariate analysis of covariance (ANCOVA) was used to 
 89 
control for baseline BSI Anxiety Index scores.  The mean baseline, two-week, and one 
month follow-up scores for completers are listed in Table 10.  
Anxiety Index.  Consistent with hypotheses, the expressive writing group reported 
significantly greater reductions on BSI Anxiety Index levels than the control group, F (1, 
129) = 6.5, p < .05, partial eta
2
 = .048 (See Table 10).  Planned contrasts revealed that 
women in the expressive writing condition showed significant improvements in BSI 
Anxiety scores, t(129) = -.288, p < .05.  Intent-to-treat analyses showed similar findings, 
F (1, 148) = 6.5, p < .05, partial eta
2
 = .043.  While short-term anxiety improvements 
differences existed between groups, analyses revealed no significant differences in 
anxiety reduction at the one-month follow-up, F (1, 119) = 0.1, p > .05.  Intent to treat 
analyses also revealed no interaction effects at the one month follow-up, F (1, 148) = 0.1, 
p > .05.  However, analyses revealed significant improvements in BSI Anxiety Index 
levels from baseline to one month follow-up for both groups.  Thus, overall 
improvements in anxiety were seen for the expressive writing group, F (1, 70) = 15.3, p < 
.005, partial eta
2
 = .181, as well as the control writing group, F (1, 50) = 6.0, p < .05, 
partial eta
2
 = .109.       
Somatic Index.  Analyses showed a trend approaching a significant interaction 
effect for the Somatic Index, F (1, 130) = 3.9, p = .05.  More specifically, while the 
control group revealed a significant increase in Somatic symptoms from baseline to two 
week follow-up, F (1, 57) = 4.4, p < .05, the expressive writing group revealed no 
significant differences in Somatic symptoms from baseline to two week follow-up, F (1, 
73) = 0.6, p > .05, thus revealing a possible protective factor of the writing.   Intent-to-
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treat analyses revealed similar findings, F (1, 147) = 3.8, p = .05.  This trend towards 
significance was not maintained at the one month follow-up, F (1, 118) = 0.6, p > .05.  
However, analyses revealed significant improvements in BSI Somatic Index levels from 
baseline to one month follow-up for both groups.  Thus, overall improvements in 
somatization were seen for the expressive writing group, F (1, 70) = 11.7, p < .005, 
partial eta
2
 = .145, as well as the control writing group, F (1, 50) = 5.2, p < .05, partial 
eta
2
 = .095.       
Contrary to hypotheses, analyses revealed no significant interaction effects 
between groups over time among the remaining seven of the nine distress indices (all > 
.05).   
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Table 10 
Effects of Expressive Writing versus Control Writing on BSI Index Scores: Short-term 
and Longer-term Follow-up 
Groups Expressive Writing Control Writing 
 Pre- 
Raw 
Score 
(SD) 
  
 
2 week- 
Raw 
Score 
(SD) 
1 month 
Raw 
Score 
(SD) 
Pre- 
Raw 
Score 
(SD) 
2 week- 
Raw 
Score 
(SD) 
1 month  
Raw Score 
(SD) 
Somatization  1.0 (0.8) 1.0 (0.8)* 0.7 
(0.8) 
0.8 (0.8) 1.0 (1.0) 0.6 (0.7) 
Obsessive-
Compulsive 
1.6 (1.2) 1.4 (0.9) 1.4 
(1.1) 
1.4 (0.9) 1.5 (0.9) 1.1 (0.9) 
Interpersonal 
Sensitivity 
1.2 (1.0) 1.1 (0.9) 1.0 (1.0) 1.0 (1.0) 1.1 (1.0) 0.8 (1.0) 
Depression 1.4 (1.0) 1.2 (0.8) 0.9 (1.0) 1.0 (0.9) 1.0 (1.0) 0.6 (0.7) 
Anxiety 1.2 (1.0) 0.9 (0.9)** 0.9 (1.0) 0.8 (0.8) 0.9 (0.8) 0.6 (0.6) 
Hostility 0.8 (0.8) 0.9 (0.8) 0.8 (0.8) 0.7 (0.7) 0.9 (0.9) 0.7 (0.8) 
Phobic Anxiety 0.8 (0.9) 0.7 (0.8) 0.6 (0.8) 0.7 (0.8) 0.6 (0.7) 0.5 (0.6) 
Paranoid Ideation 1.4 (0.9) 1.4 (0.9) 1.3 (1.0) 1.2 (0.9) 1.3 (0.9) 1.0 (0.8) 
Psychoticism 1.3 (1.0) 1.2 (1.0) 1.0 (1.0) 1.1 (0.8) 1.0 (0.9) 0.7 (0.8) 
General Severity 
Index 
1.2 (0.8) 1.0 (0.7) 0.9 (0.6) 1.0 (0.7) 1.0 (0.8) 0.7 (0.8) 
** p < .05; * p = .05 
 
Hypothesis 3 
It was hypothesized that women randomized to the expressive writing group 
would show higher levels of immediate distress (measured immediately after each 
writing session) and lower levels of longer-term distress (measured at two weeks and one 
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month post-baseline assessment) relative to those in the control group.  Furthermore, 
while those in the expressive writing group were expected to show higher levels of 
immediate distress, it was predicted that these increases would be short-lived, revealing 
no difference in pre-writing scores the following day.   
Consistent with hypotheses, there was a significant time by condition interaction, 
F (4, 144) = 9.6, p < .005, partial eta
2 
= .211.  In addition, univariate F tests revealed that, 
as predicted, the groups did not differ in negative affect prior to writing, suggesting that 
the immediate increase in negative affect after writing was ephemeral.   
Consistent with predictions, univariate tests revealed a significant interaction 
between time by condition at writing session one, F(1,147) = 28.9, p <.005, with a 
significant group main effect, partial eta
2 
=.16.  There was a significant interaction 
between time by condition at writing session two, F (1, 147) = 16.1, p < .005, with a 
significant group main effect, partial eta
2 
= .10.  The interaction continued to be 
significant at writing session three, F (1, 147) = 9.9, p < .005, with a significant group 
main effect, partial eta
2 
= .06.  At writing session four, however, there was no significant 
interaction, F (1, 147) = 2.2, p > .05.  As illustrated, analyses revealed that the main 
effects decreased over time.  By the final writing session, participants in the expressive 
writing condition were possibly becoming habituated, and able to write about 
traumatic/stressful events without having the spike in negative affect over time (e.g., 
emotional arousal and habituation).   
However, contrary to hypotheses, results showed no significant effect of group on 
distress levels at either the two week or one month follow-up, p > .05.  
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Table 11 
Negative Affect: Pre-Post Writing and Follow-Up 
  
Session Expressive Writing 
Mean (SD) 
Control Writing 
Mean (SD) 
Writing Session 1 Time 1 18.7 (7.9) 16.2 (7.2) 
Writing Session 1 Time 2  24.0 (10.9) 15.2 (8.2) 
Writing Session 2 Time 1 17.6 (8.2) 13.3 (4.9) 
Writing Session 2 Time 2  22.4 (11.2) 13.5 (5.2) 
Writing Session 3 Time 1 16.8 (7.7) 14.1 (6.2) 
Writing Session 3 Time 2 19.5 (9.5) 13.4 (5.1) 
Writing Session 4 Time 1 17.6 (8.4) 13.9 (6.2) 
Writing Session 4 Time 2 18.7 (9.0) 13.6 (5.4) 
Two Week Follow-up 
(n=132: N = 74, N = 58) 
15.2 (5.1) 
 
13.8 (4.8) 
 
One Month Follow-up 
(n =120; n = 70; n =50) 
15.3 (7.0) 13.1 (4.6) 
**It should be noted that the Time 1 PANAS was assessed after writing instructions were 
given, but prior to writing. 
 
Validity of Group Assignment 
Essay Evaluation Measure.   As shown in Table 12, the expressive writing group 
reported their essays as more meaningful, t (139) = 9.1, p  < .0005, more personal, t (139) 
= 13.3, p  < .0005, more revealing of one‘s emotions, t (139) = 18.0, p  < .0005, and more 
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likely to have wanted to discuss it with others, t (139) = 8.7, p  < .0005, than did control 
group participants.  They also reported being more likely to have actually talked with 
others about the event(s), t (139) = 10.0, p < .0005, and also to have actively held back 
from talking with others about the events, t (139) = 4.5, p < .0005 than did control group 
participants.   
Table 12 
Essay Evaluation Measure scores (average item answer) for Expressive Writing (n = 77) 
and Control Writing (n = 64) 
 Expressive 
Writing  
Mean (SD) 
Control 
Writing 
Mean (SD) 
P 
―The essay was meaningful.‖  6.2 (1.3) 3.9 (1.7) < .0005 
―The essay was personal.‖ 6.2 (1.5) 2.7 (1.7) < .0005 
―The essay was revealing of my emotions.‖ 6.2 (1.2) 2.2 (1.4) < .0005 
―I wanted to talk to others about the event(s) 
that I wrote about.‖ 
4.0 (1.8) 1.8 (1.0) < .0005 
―I have actually talked to others about the 
event(s) that I wrote about.‖ 
4.1 (1.9) 1.5 (0.9) < .0005 
―I have actively held back from talking to 
others about the event(s) that I wrote about.‖ 
4.2 (1.7) 2.8 (1.9) < .0005 
  
Follow-up Questionnaire.  As shown in table 13, the expressive writing group 
was significantly more likely than the control writing group to report finding the writing 
to be helpful, 2 (2, N = 120) = 18.6, p < .005, to continue journaling using the writing 
instructions given during the study after the writing sessions ended, 2 (2, N = 120) = 
10.8, p < .005, and to have talked about the subject matter from their essays with 
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someone during their treatment at Rubicon, 2 (2, N = 120) = 8.8, p < .005.  Most 
(85.7%) of the expressive writing participants who talked about the subject matter from 
their essays with someone during treatment found it to be helpful.   
 
Table 13 
Follow-up Questionnaire at One Month Follow-up: Expressive Writing (n = 70) and 
Control Writing (n = 50)  
  
 Expressive 
Writing 
%  
Control Writing 
%  
Did you find the writing helpful? 98.6%** 72.0% 
Did you talk about the subject matter from your essays with 
anyone during your treatment at Rubicon?  
15.9%** 0.0% 
If yes, did you find it helpful to talk about the subject 
matter from your essay? 
100.0%** n/a 
Did you continue writing using the instructions given 
to you after the writing sessions had ended? 
42.0%** 14.0% 
* p < .005 
As a fidelity check, the Follow-Up Questionnaire asked whether participants 
heard any clients at Rubicon discussing the writing instructions for this study, and a total 
of n = 2 (1.7%) reported hearing about the instructions from another client at Rubicon 
(both were control writing participants).  The following question, which asked what the 
participants ‗thought‘ the other writing instructions were about, confirmed that these were 
the only two participants who heard about the other writing instructions. 
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Discussion 
The purpose of the present study was to collect benchmark data on whether 
Pennebaker‘s expressive writing paradigm could be applied to women currently in 
residential SUD treatment.  The study first described rates of trauma, physical health 
problems, distress, depression, and drug craving in a sample of drug dependent women 
assessed within days of admission to residential treatment.  It then examined whether co-
morbid PTSD and/or trauma-related symptomatology was associated with more severe 
psychiatric and physical health problems.  Next, in a clinical trial, it compared changes in 
physical and psychiatric symptom severity in women randomized to either an expressive 
writing or neutral topic writing control group.  Both conditions were provided over 4 
consecutive days in the context of residential SUD treatment.  It was hypothesized that 
women in the expressive writing group would report greater reductions in symptoms 
related to PTSD than women in the neutral topic control group.  Finally, the study looked 
at patient safety and investigated whether expressive writing increased the risk for early 
treatment discontinuation or increased levels of trauma-related distress and other 
psychological/physical health problems.   
Epidemiology of Trauma and PTSD in Women with SUDs   
Study participants reported rates of trauma comparable to those previously 
reported in the literature, supporting the rationale for the clinical trial and study 
hypotheses (Dansky, Saladin, Brady, Kilpatrick, & Resnick, 1995; Hien, Cohen, & 
Campbell, 2005). Specifically, the present study found nearly all women (96%) 
experienced at least one lifetime traumatic event severe enough to warrant a PTSD 
 97 
diagnosis.  Since co-morbid trauma seems to be the norm, rather than the exception 
among women in treatment for SUDs, findings confirm the importance of screening for 
trauma in such settings.  Sadly, the majority of women with SUDs are neither evaluated 
for PTSD nor provided treatment for trauma (Najavits, 2006).  In addition, many women 
underreport or deny such symptoms, resulting in missed opportunities for intervention 
(Gutierres & Van Puymbroeck, 2006).  Similar patterns are seen in mental health settings, 
where trauma is the focus of treatment and co-morbid SUDs often go undetected.  Such 
‗split systems‘ of care (where mental health clinicians feel unable to sufficiently assess or 
address SUDs, while SUD clinicians feel unable to assess or address trauma) are the 
norm, despite the fact that such programs are believed to be less effective than concurrent 
or integrated treatment (Najavits, 2006). 
Compatible with previous research (e.g. Fullilove, et al., 1993; Kessler, Sonnega, 
Bromet, Hughes, & Nelson, 1995; Najavits, et al., 1997), the current study found that 
over half (54.4%) of participants met diagnostic criteria for current (past month) PTSD.    
These rates are consistent with studies showing current PTSD among women in 
substance treatment settings range from 30% to 59% (Najavits, et al., 1997), compared to 
PTSD rates in the general population which range from 1% to 9% (Kessler, et al., 1995).   
The present study also found that, regardless of PTSD diagnostic status, 
participants reported a mean of 3.7 different types of trauma events at baseline.  These 
numbers reflect similar amounts and types of trauma events as those reported in previous 
research with substance dependent women, with an average of 4 different types of trauma 
per woman (e.g. Brown, Stout, & Mueller, 1999).  In addition, the present study found 
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that number of different types of traumatic events were significantly higher in SUD 
women with a co-morbid current diagnosis of PTSD as compared to those without PTSD 
(M = 4.6 versus M = 2.8, respectively).  It should be emphasized that these analyses 
compared number of different types of traumatic events experienced, and not the overall 
frequency with which participants experienced traumatic events.  Many of the women in 
the present study experienced repeated traumatic events within the same type of trauma, 
which is not reflected in the data.  Taken together, the present study confirms that 
repeated trauma is pervasive among female SUDs and reinforces the need for programs 
to concurrently address both SUD and co-morbid PTSD/trauma, because interventions 
focused on only one of the two disorders may be inadequate and lead to poorer outcomes. 
The specific nature and prevalence of trauma found in the present study 
corresponds with earlier studies (e.g., Brown, Stout, & Mueller, 1999; Coffey, et al., 
1998), and most of the traumas were of an interpersonal and violent nature.  Research 
suggests that interpersonal trauma is more likely than accidents or natural disasters to 
result in co-occurring symptoms and problems that go beyond PTSD-SUDs, such as 
depression, somatic complaints, disassociation, impulsive behavior and anger 
management problems (Cohen & Hien, 2006; Roth, Newman, Pelcovitz, van der Kolk, & 
Mandel, 1997).  Furthermore, if an individual is using drugs to self-medicate, once 
outside of residential treatment (if traumas are not properly addressed during SUD 
treatment) she will be more likely to experience a repeat trauma, which may increase the 
likelihood of relapse to drug use.  Thus, by addressing trauma, we can hopefully help 
prevent further re-victimization.   
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High rates of PTSD in women with SUDs warrant more attention from the 
addiction treatment community.  It is imperative that counselors recognize the 
heterogeneous ways in which PTSD can affect their patients and drug abuse treatment.  
The extent and duration of symptoms, as well as the degree of social and functional 
impairment, co-morbidity, and somatization should be carefully monitored and evaluated 
(Breslau, 2001).  SUD treatment providers can no longer ignore this co-morbid disorder.  
They must improve their approach for identifying PTSD and trauma symptoms and 
creative ways to link women with appropriate treatment services, either on-site or 
through community referral.  Failure to do so is likely to reinforce premature treatment 
drop out and poorer (Brown, Stout, & Mueller, 1999). 
Clinical Profiles and Treatment Response in SUD Women with and without PTSD 
The first hypothesis was supported by the data, with poorer health and more 
severe clinical profiles in SUD women with PTSD or PTSD-related symptomatology, as 
compared to those without such co-morbidities. 
Trauma and Health among Women with SUDs.  The present study revealed that 
SUD women with co-morbid PTSD have significantly more physical health symptoms 
and sensations compared to SUD women without PTSD.  Thus, while SUDs are 
associated with a wide range of physical and mental health detriments, PTSD confers an 
even greater risk and detriment (Ouimette, Goodwin, & Brown, 2006).  These women 
have disproportionate physical health burdens and are especially susceptible to risk 
factors related to poor health and disability.   
 100 
The poor health of these women may be a sign of persistent obstacles toward 
obtaining sufficient medical attention as well as complications connected with their 
substance abuse or psychological problems; furthermore, there are undeniably special 
needs that medical providers might not identify or be prepared to sufficiently manage, 
given the issues faced by women who have a combination of substance abuse and trauma 
(Larson, et al., 2005).  While there is currently concern among some SUD treatment 
providers that integrated trauma treatment poses a danger for increasing the patient‘s 
adverse psychiatric and physical symptoms (Hien, et al., 2004), present study findings 
underscore a need for interventions aimed at facilitating improved health outcomes 
among co-morbid SUD-PTSD patients who seek residential treatment, as these women 
are at greater risk for physical health problems.   
Clinical Profiles among Women with SUDs and Trauma.  In addition to physical 
health problems, the present study supports previous research showing that women with 
co-morbid SUD and PTSD experience greater levels of psychological distress across a 
host of domains compared to those without trauma histories (Clark, et al., 2001; Coffey, 
et al., 2005; Najavits, et al., 1997;).  Since women with SUDs already experience a 
disproportionate amount of psychological distress compared to women in the general 
(non-clinical) population, these findings highlight the fact that the presence of both of 
these syndromes confers still greater risk and severity of psychological distress.   
Scores for all nine primary dimensions of the BSI as well as the General 
Symptom Severity Index were significantly higher in SUD women with co-morbid PTSD 
as compared to those without PTSD.  Again, findings are congruent with the research 
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literature, which shows more severe clinical profiles and interpersonal problems in dually 
diagnosed females as compared to females with only one of the two disorders (Brown, et 
al., 1999; Najavits, et al., 1999; Ouimette, Wolfe, & Chrestman, 1996).  However, it is 
also important to note that there is general overlap between PTSD symptoms and BSI 
index scores; therefore, these findings are not too surprising, yet still reflect significant 
difficulties experienced by this particular population.  Still, research shows that a history 
of abuse and trauma, regardless of gender, race, or other mental disorders or criminal 
activity, is related to a lower likelihood of posttreatment abstinence among adults in drug 
abuse treatment (Boles, Joshi, Grella, & Wellisch, 2005).  Thus, there is considerable 
evidence that further clinical research may be required to in order to more effectively 
help these women and improve interventions for handling these co-morbid problems 
without triggering more harm.   
Depression among Women with SUDs and Trauma.   Since depression is a 
common co-morbidity in women with SUDs, it was important to look specifically at 
depressive symptoms in SUD women with and without PTSD.  As expected, the present 
study found nearly three fourths of participants (72.5%) obtained clinically elevated 
depression scores at baseline assessment.   Women with co-morbid PTSD reported 
significantly higher depression levels as compared to those without PTSD.  Furthermore, 
women with clinically elevated depression levels (CES-D ≥ 16) reported greater trauma 
symptom severity as compared to those without clinically elevated depression.  
Therefore, the current study supports previous evidence suggesting that SUD women 
with a history of PTSD and trauma are more likely than those without PTSD to be 
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diagnosed with depression and to report higher rates of depressive symptoms (Clark, et 
al., 2001).   
While the present study did not formally assess for DSM-IV disorders other than  
PTSD and substance abuse/dependence, findings suggest that it is likely that some of 
these women would have met criteria for a mood disorder, as well (e.g., Major 
Depressive Disorder, Dysthymia).  Using a sample of mothers with PTSD (n = 801), 
Breslau (2001) found that 43.2% of the women had Major Depression that was secondary 
or co-morbid with conditions like SUDs.  In another study comparing SUD patients with 
and without co-morbid PTSD, 79% of SUD patients with PTSD had Major Depressive 
Disorder, compared to 51% of SUD patients without co-morbid PTSD (Brown, Stout, & 
Mueller, 1999).  Dysthymia is also significantly more prevalent among SUD patients 
with PTSD as compared to SUD patients without PTSD (19% versus 6%, respectively) 
(Brown, Stout, & Mueller, 1996).   
The presence of PTSD, a SUD, and/or depression appears to increase the risk of 
developing the other disorder, and these findings are consistent across various kinds of 
trauma and substances of abuse (Najavits, Weiss, & Shaw, 1997).  While high 
comorbidity rates indicate that PTSD and SUDs are functionally related, the mechanisms 
underlying the development of this relationship is not clear (Back, Brady, Sonne, 
Verduin, Back, et al., 2006).  While alcohol and drugs may be used to self medicate to 
avoid trauma reminders and related distress, the lifestyle of someone with drug use 
problems may predispose these individuals to endure traumatic events (Johnson, Striley, 
& Cottler, 2006; Reynolds, et al., 2005).  Also, depression can put women at an increased 
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risk for SUDs, which can place them at-risk for trauma.  Another theory suggests that an 
independent third factor, such as genetic and/or environmental influences, may contribute 
to the high co-occurrence of these problems (Brown & Wolfe, 1994; Xian, et al., 2000).  
While the present study did not examine the time course for development of the various 
disorders and differences in age of onset, it appears that any one of these problems 
enhances the likelihood of the other problem co-occurring.   
Drug Craving and Drugs of Dependence among Women with SUDs and Trauma.  
Contrary to previous research showing that violent trauma and distress are correlated with 
severity of drug use (e.g., Clark, et al., 2001), the present study did not find drug craving 
to be related to trauma.  While craving is just one aspect of what would be considered 
‗severity‘ of drug use, several factors may contribute to our failure to find a relationship 
between craving and trauma.  First, many of these women came from a controlled setting 
prior to enrolling in Rubicon‘s residential program (e.g., prison, detox, etc.).  Thus, the 
period of abstinence from drugs prior to treatment enrollment may have reduced overall 
drug craving scores (Da Silveira, Doering-Silveira, Niel, & Jorge, 2006), possibly 
influencing how much participants were ‗currently‘ craving the drug.  In addition, some 
research suggests that overall low craving scores tend to be found once a patient is out of 
her ―natural environment‖ (Garavan, et al., 2000).  Furthermore, it is possible that the 
null findings are in part due to the instrument used to measure craving.   
The measure that was used revealed a low reporting of drug craving and relatively 
low variability.  Therefore, the Brief Substance Craving Scale (Somoza, 1999) that was 
used to measure craving was essentially dropped from further analyses in the present 
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study.  It is believed that there was a low ability to detect drug craving appropriately with 
the brief measure used.   
The present study also did not find significant differences in drug(s) of 
dependence between women with co-morbid PTSD and women without PTSD.  While 
some studies have found that ―harder‖ drugs, such as cocaine and heroin, are more 
strongly related to trauma and PTSD (Grice, et al., 1995; Miller, Downs, & Testa, 1993; 
Najavits, Weiss & Shaw, 1997), other studies have found that PTSD and trauma severity 
are unrelated to drug preference and seem more generally linked to the disorder of drug 
dependence (Johnson, Striley, & Cottler, 2006).   
One thing to consider is that most of these women reported a primary drug of 
either cocaine (81.9%) or heroin (45.0%), and many of the women reported having more 
than one drug of dependence.   Furthermore, while 28.9% of the women in the present 
study reported alcoholism and 10.1 % reported marijuana dependence, many of these 
women used other ―harder‖ drugs as well, contributing to rates of polydrug 
use/dependence.  In addition, homogeneity is present in the target sample because a 
certain level of drug severity is generally required before residential services are offered 
as a treatment option.  To illustrate, women generally do not get admitted into Rubicon‘s 
residential program for marijuana dependence alone.  As mentioned in the Methods 
section, there was also a period of time when the present study excluded women with 
alcohol dependence as a primary problem, since alcohol dependent women were being 
recruited for another randomized clinical trial specific to women with an alcohol use 
disorder.    
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Shorter Term and Longer Term Effects of Expressive Writing in SUD Women 
In support of the second hypothesis, results from the present study indicate that 
expressive writing participants demonstrated greater reductions in post-traumatic 
symptom severity and anxiety scores than control writing participants.  However, there 
were no significant interaction effects with the other psychological and physical health 
measures.  While no group differences were found at one month follow-up, both groups 
showed significant positive changes, which is likely due to being in residential treatment 
for 30 days (Bartels & Thomas, 1991).  
Trauma Symptom Severity.  In support of hypothesis two, the present study found 
that women in the expressive writing condition demonstrated significantly greater 
improvements in levels of traumatic stress compared to women in the control writing 
condition at the two week follow-up.  More specifically, those in the expressive writing 
condition indicated significant reductions in trauma symptom severity levels, while 
control writing participants indicated no improvements in symptom severity.  At the one 
month follow-up, however, improvements were seen regardless of writing condition, and 
there were no significant differences in trauma symptom severity improvements between 
expressive writing and control writing participants. 
Overall, short-term findings were consistent with previous research with other 
pools of participants suggesting that writing about emotional experiences using 
expressive writing results in a decreased degree to which the experience is distressing or 
 106 
painful (Lepore & Smyth, 2002; Sloan, Marx, & Epstein, 2005).  One potential reason for 
these findings is based on the exposure theory.  This theory suggests that an individual‘s 
attempt not to think about traumatic/stressful experiences in order to avoid becoming 
overwhelmed by emotions (avoidance behavior), may generate further feelings of distress 
and fear associated with the trauma (Lepore, Greenberg, Bruno, & Smyth, 2002).  Thus, 
expressive writing may act as a medium that allows the individual to be exposed to 
unpleasant stimuli that had been previously avoided.  Repeat exposure over several 
writing sessions may allow for habituation and extinction of negative emotional 
associations and/or activate the fear structure and offer corrective information to the 
person about the stimuli, responses, and meaning of the event (Sloan & Marx, 2004).  
The concept that exposure to feared stimuli can bring about appropriate management of 
emotional matter appears applicable to the written disclosure paradigm, as it may help 
alleviate distress by conquering one‘s propensity to avoid or suppress upsetting memories 
and emotions.  
While it is generally thought that exposure to the same traumatic event is essential 
for extinction in other exposure therapies, the expressive writing task does not require 
that the individual write about the same event at each writing session, suggesting that 
stimulus-related habituation can take place regardless (Sloan & Marx, 2004; Lepore, et 
al., 2002). Studies to-date comparing instructions for participants to write about the same 
or different topics each day have yielded mixed results. 
One recent study using a population of college students with a history to trauma, 
found that participants who wrote about the same trauma experience at each session 
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showed improvements at follow-up, while participants instructed to write about a 
different trauma each day did not (Sloan, Marx, & Epstein, 2005).  Other studies have 
obtained more robust results when participants were allowed to choose their writing topic 
at each session (Pennebaker, 1997; Smyth, 1998).  
While the present study did not instruct women to write about the same event or 
different events across the four writing sessions, further investigation of the essays are 
needed to determine how many women focused on a single event versus multiple events.  
The relationship between essay topic consistency and outcome measures warrants further 
study, recognizing that other factors (types of traumas experienced, recency of trauma) 
may influence participant decision making.  Also, some women may benefit most by 
writing about the same trauma across all sessions, while others may be better served by 
writing about different events at each session (Sloan, et al., 2005). 
While the present study found significant short-term improvements in trauma 
symptom severity among expressive writing participants relative to the control writing 
participants, significant differences between conditions were not maintained at the long-
term follow-up.  These findings are consistent with the literature that suggests that 
benefits made through the written disclosure task may dissipate rapidly over time (Sloan 
& Marx, 2004).    
The present study is unique, however, in that it was conducted in the context of 
residential treatment, which, in and of itself, is likely to produce improvements in 
physical and psychosocial functioning over time.  Thus, while expressive writing and 
control writing groups did not differ at one month follow-up, both groups demonstrated 
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positive changes on core outcome measures. Also, results affirm that expressive writing 
did not have a detrimental effect at one month follow-up.       
The importance of short-term improvements at two weeks versus one month, 
should not be discounted, particularly since we are dealing with a clinical population and 
a chronic disorder.  While demonstrating significant improvements over the control 
writing condition at the one-month follow-up would have been ideal, it is not surprising 
that such severe trauma and/or PTSD (as was found in the present study), was not 
alleviated by such a brief psychosocial intervention.   
The ability to reduce trauma symptom severity early in drug treatment can be 
beneficial in many ways (e.g., increasing patient ability to concentrate during counseling 
sessions, reducing risks for leaving treatment prematurely, reducing risks for relapse to 
drug use).  Thus, future studies should explore whether extending the intervention in 
ways that maintain or further ‗boost‘ short-term improvements at a later time, possibly 
through more writing sessions distributed over the course of SUD treatment, may 
enhance longer-term effects.  
Koopman and colleagues (2005), for instance, suggested that writing for a total of 
80 minutes (20 min sessions over 4 consecutive days) was possibly not enough to 
ameliorate PTSD symptoms in general among women with intimate partner violence 
(IPV), and that instructing women to write about the IPV experiences (versus writing 
about any traumatic/stressful event) may have been more helpful in reducing PTSD 
symptoms.  In another study examining the utility of expressive writing with individuals 
with PTSD (clinical population), Smyth, Hockemeyer & Tulloch (2008) found decreases 
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in PTSD symptom severity from baseline to follow-up for both groups, but like us, found 
no significant difference between the expressive writing and control writing group in 
PTSD symptom changes at longer-term follow-up.  
Depression. Contrary to hypotheses, there were no significant interaction effects 
over time (at two weeks or at one month) in the reduction of depressive symptoms 
between the two writing conditions.  These findings stand in contrast to previous studies 
of depression in college undergraduates (Gortner, Rude, & Pennebaker, 2006; Lepore, 
1997, Sloan, Marx, & Epstein, 2005).  They are congruent, however, with previous 
research targeting clinical populations (Frisina, Borod, & Lepore, 2004).  For instance, a 
meta-analysis of expressive writing in clinical and medical populations (four clinical 
sample studies; five medical sample studies) found expressive writing was less effective 
for psychiatrically as compared to physically ill patients (Frisina, et al., 2004).   In 
addition, it is important to remember that both the experimental and control groups in the 
present study had significant reductions in depressive symptoms at one month follow-up, 
which was likely associated with having spent 30 days drug free in a supportive 
residential SUD treatment setting. 
As the number of expressive writing studies with clinical populations grows, 
findings have begun to indicate that supplemental interventions may be required in order 
to enhance the benefits gained from the general expressive writing task.  It is also more 
apparent that there are potential moderating variables (e.g. instructional set for written 
disclosure) and mediating variables (e.g., role of cognitive processing, which can be 
analyzed through content analysis), that may impact the beneficial effects of the writing 
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paradigm (Frisina, et al., 2004).  Understanding these moderating variables may help us 
to better understand how expressive writing can effectively influence depression levels.   
For instance, while Gortner and colleagues (2006) found improvements in 
depression among those in the expressive writing condition (versus the control writing 
condition) in a depression-vulnerable college population, these improvements were seen 
only among less expressive participants (those with high Emotion Regulation 
Questionnaire Suppression scores), and were mediated by changes is brooding but not 
reflection scores.  Thus, results suggest that individuals who were less expressive may 
have had a greater need for the opportunities that expressive writing treatment offers.   
Physical Health Problems. Contrary to hypotheses, there were no significant 
interaction effects over time (two week or one month) in the reduction of physical health 
symptoms and sensations between the two writing conditions.  This finding conflicts with 
an extensive body of research suggesting positive physical health benefits from 
expressive writing (e.g., Pennebaker & Beall, 1986; Smyth, et al., 1999).  However, 
results showed overall improvements in physical symptoms and sensations for all 
participants, regardless of group assignment, at the one month follow-up assessment, 
which is likely due to having received 30 days of residential care. 
 While we did not find the health improvements we expected from the expressive 
writing task, it is also important to remember that the present study uses a sample of 
women who, generally speaking, were receiving little to no healthcare treatment prior to 
admittance at Rubicon.  Once admitted into the residential treatment facility (baseline 
assessments were conducted within the first week of treatment), however, these women 
 111 
began receiving psychotherapy and/or medication, which likely influenced symptoms and 
self-reports at follow-up, above and beyond improvements we may otherwise witness as 
a result of the disclosure paradigm.   
It is also important to note that these participants are at-risk for chronic health 
problems, such as diabetes, hepatitis C, HIV, etc., (unfortunately, the present study did 
not collect data on this information), and there was likely a wide variation of health 
problems (both chronic and acute) at the start of treatment among these women.  As a 
result, the present sample could have had an elevated level of pre-existing variance 
(noise), which as a result, could have inhibited our capability to interpret the 
effectiveness of expressive writing on health (Frisina, et al., 2004).   
Another thing worth mentioning is that there is a full-time nurse at Rubicon 
working hard to address all medical-related needs.  Thus, participants received 
continuous care for their medical needs as well as medication to address physical illness 
from the moment they arrived at Rubicon.  As noted, the present study found 
improvements in health related symptoms for people in both writing conditions.  
Therefore, what our findings suggest is that the writing paradigm did not have a large 
enough impact on physical health symptoms and sensations above the improvements 
generally seen.   
There are also many ways that previous expressive writing studies have examined 
health outcomes.  Self-report data is one way to examine health, but certainly not the only 
way.  For instance, many studies have examined physician visits, physiological markers, 
and behavioral makers in order to assess health outcomes.  Another way to have 
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measured physical health with the present sample would have been to record the number 
of groups missed due to feeling ill (we do not have actual numbers, but it is not 
uncommon for residents to miss groups due to feeling ill), which may have provided a 
different/more effective way of measuring health improvements (Pennebaker, 1997).  
Furthermore, longer term follow-up outside of residential care, would be another way to 
assess for physical health effects.   
Anxiety Index from Brief Symptom Inventory.  Consistent with hypotheses, the 
expressive writing group reported significantly greater reductions in BSI Anxiety Index 
levels than the control writing group at the two week follow-up.  Contrary to hypotheses, 
however, there were no significant main effects in anxiety at the one-month follow-up.   
Short-term findings from the present study may suggest that expressive writing 
assists with emotion regulation through attention, habituation, and cognitive restructuring 
(Lepore, Greenberg, Bruno, & Smyth, 2002).  Expressive writing can potentially help 
influence attention toward or away from different parts of a stressor, and through repeat 
exposure, habituation may have occurred during writing (Lepore, et al., 2002).  Foa 
(1997) contends that for successful habituation, an individual should undergo strong 
negative emotions initially, but then show steady reductions in negative emotions over 
time (see below in discussion of hypothesis three).  Another theory suggests that 
cognitive restructuring may initiate changes in stress-related thoughts and appraisals.  To 
the degree that people can cognitively incorporate stressful experiences, they should 
experience a decrease in and possible extinction of anxiety and intrusive thoughts.   
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The one month findings on anxiety in the present study are contrary to 
predictions, but consistent with some research suggesting no differences between 
expressive writing and neutral writing conditions in anxiety reduction (Kloss & Lisman, 
2002).  Studies examining essay content have also revealed that language categories, such 
as negative emotion words, are related with differing levels of anxiety among women in 
the expressive writing condition (Smith, Anderson-Hanley, Langrock, & Compas, 2005).  
Based on the emotional processing theory, we might expect to find that participants who 
wrote about the same experience, versus different experiences across all writing sessions, 
would benefit most from the writing paradigm.   
Somatic Index from the Brief Symptom Inventory.  Analyses in the present study 
revealed a trend approaching significance for the BSI Somatic Index.  More specifically, 
control writing participants revealed a significant increase in somatic symptoms at the 
two week follow-up, while expressive writing participants showed no changes in somatic 
symptoms from baseline to the two week follow-up.  Thus, results might suggest that 
expressive writing could have a protective effect on drug dependent women during the 
early stages of residential treatment.    
If drug dependent women are likely to reveal initial increases in somatic problems 
(within the first couple weeks of residential treatment), possibly as a result of their bodies 
readjusting to no longer being physically dependent on drugs, then written emotional 
disclosure may benefit women by preventing somatic deterioration.  The notion that the 
expressive writing paradigm may serve as a protective influence is particularly 
noteworthy considering that there had historically been concerns over adverse reactions 
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or negative experiences attributed to an integrated trauma-related and SUD treatment 
(e.g., Killeen, Hien, Campbell, Brown, Hansen, Jiang, et al., 2008).  
Remaining BSI Indices.  Contrary to hypotheses, there were no significant 
interaction effects over time (two week or one month) for the remaining BSI distress 
indices.  Consistent with previous analyses, however, we did find general improvements 
across all indices on the BSI at the one month follow-up for both writing groups.  
Effects of Expressive Writing on Immediate and Longer-Term Levels of Distress 
Consistent with hypothesis three, women randomized to the expressive writing 
condition showed greater levels of immediate distress (post-writing negative affect 
scores) relative to those in the control writing condition.  In addition, negative affect 
measured prior to the writing session the next day (pre-writing negative affect scores) 
revealed no differences between the two writing conditions.  Contrary to predictions, 
however, expressive writing did not produce significant longer-term improvements in 
negative affect over control writing.  Participants in both writing conditions, however, 
displayed decreases in negative affect at the two-week and one-month follow-up.  These 
longer term findings may be primarily a result of residential treatment improvements 
overshadowing potential group differences. 
Although writing about traumatic/stressful experiences can be psychologically 
painful in the short run, over time there appears to be decreased negative affect associated 
with writing about the traumatic or stressful experience.  As predicted, the groups did not 
differ in negative affect on days 2 – 4 prior to writing, suggesting that the immediate 
increase in negative affect after writing was temporary.   
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Increased short-term negative affect immediately following writing is consistent 
with previous literature in the area (Esterling, L‘Abate, Murray, & Pennebaker, 1999), 
and provides evidence for emotional engagement and (fear) activation (Kloss & Lisman, 
2002).  Experts in the field of trauma claim that emotional engagement is essential for 
habituation to occur (Foa, 1997).  In order for successful habituation to occur, an 
individual should endure strong negative emotions initially (Lepore et al., 2002), 
followed by gradual reductions in negative emotions within and across writing sessions, 
as was seen in the present study.   
Such habituation may indicate desensitization to trauma-related memories and 
thoughts (i.e., stimulus-specific habituation), and possibly an enhanced tolerance of the 
individuals‘ negative emotional responses to stress-provoking stimuli in general (i.e., 
response-specific habituation; Lepore, et al., 2002).  Thus, initial spikes in distress and 
consequent habituation may be reflective of emotional processing and enhanced self-
regulation, and should be associated with improvements in one‘s reaction (psychological 
and physical) to trauma memories (Sloan, Marx, Epstein, & Lexington, 2007).   
While expressive writing did not result in significant longer term improvements in 
negative affect over the control writing, it is possible that instructing participants to write 
about the same or different experiences across all four days could have played a role in 
these null effects.  While writing about the same experiences across all four days should 
enhance exposure, it has been suggested that writing about different experiences may 
weaken exposure (Kloss & Lisman, 2002).  Further analyses should compare distress 
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ratings for those who wrote about the same traumatic/stressful experiences versus 
different experiences across all four days.   
Since control writing participants evinced relative decreases in negative affect, 
results may indicate that improvements in distress is a product of intensive residential 
treatment, as well.  It is important to point out, however, that due to the short-term 
findings, Pennebaker‘s expressive writing paradigm appears to be practical for use in 
women with SUDs, as the writing task generates the same immediate responses as it does 
for other, non-clinical populations.   
Expressive Writing with Drug Dependent Women 
This project examined whether expressive writing improved outcomes in a 
residential-based sample of women with SUDs.  Women were able to safely express their 
deepest emotions and thoughts, many for the first time, about a traumatic and/or stressful 
event that occurred.  Expressive writing was a safe way for them to express and process 
their feelings.  During the follow-up assessments, the majority of women who were in the 
expressive writing condition reported that the writing helped them work through issues 
and problems, and deal more effectively with feelings and emotions related to trauma and 
stress.  These reports were offered spontaneously by the participants, was well as when 
providing responses to the Follow-Up Questionnaire.   
The women who present for treatment at Rubicon are somewhat homogenous in 
the sense that the majority have less than a high school level of education, are under-
employed or unemployed, uninsured, single/never married, and thus are a vulnerable 
population with a variety of medical and psychosocial problems and fewer resources than 
 117 
others with SUDs.  The study population also represents women of diverse race, 
substance use diagnoses, and psychiatric symptom severity.  It is noteworthy that in a 
population that generally has difficulty adhering to treatment, expressive writing was 
well-received and regarded as helpful by the participants themselves.    
 While findings suggest some loss in ability to see group differences because of 
the positive changes associated with 30 days of residential drug treatment, we gained in 
rates of adherence.  Furthermore, retention for the intervention and follow-up assessment 
would likely not have been obtained in an outpatient setting, and the intervention, itself, 
could have raised safety issues.  However, the present study showed a strong retention 
rate (94.6% completed all four writing sessions, 88.6% completed the two-week follow-
up, and 80.5% completed the one-month follow-up), which is higher than most other 
studies of substance dependent populations (Najavits, Weiss, Shaw, & Muenz, 1998).    
Women in the expressive writing condition also reported finding the writing to be helpful 
(98.6%), and many continued writing on their own (42.0%) after study completion, using 
the instructions given during the study.   
The present study also provides evidence for the fidelity of the writing 
intervention in a residential SUD treatment center, as those writing about stressful or 
traumatic experiences were experiencing the anticipated responses per Essay Evaluation 
Measures and PANAS scores.  Those in the expressive writing condition reported that 
their essays were more meaningful, personal, and revealing of their emotions compared 
to the control group.  Topics of the expressive writing essays were also written about a 
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severe trauma or stressor, and more likely to still be influencing their lives, compared to 
the control writing condition.   
Together, these findings indicate that addressing trauma-related issues 
concurrently with substance abuse treatment was well-received by study participants.  
Additionally, women in the expressive writing condition either improved more than, or as 
much as, those in the control writing condition on measures of physical and 
psychological health at follow-up.  While the lack of adverse events is not a telltale sign 
of treatment efficacy, it does inform treatment providers that implementing such trauma-
focused interventions can be done without triggering more harm, and can possibly work 
to enhance current treatment procedures (Killeen, et al., 2008). 
Expressive Writing at One Month Follow-Up in a Residential SUD Treatment Program 
Since expressive writing research has historically been conducted mostly with 
healthy college students, and has only recently been extended to include medical and 
clinical populations, we are still early on in our understanding of how and for whom this 
paradigm works.  Nevertheless, it has been suggested that expressive writing might be 
less effective for people who indicate very high levels of psychopathology and/or with 
treatment-seeking samples (Sloan & Marx, 2004).  Further, recent research suggests that 
high risk individuals may require supplemental interventions (e.g., therapy, trauma-
related skills training) in order to obtain maximal benefits from expressive writing 
(Smyth, Hockemeyer, & Tulloch, 2008).   
Furthermore, while the content of individual essays was not examined in the 
present paper, it would also be an important issue to consider in facilitating our 
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understanding of how to best use the written disclosure procedure as well as what 
moderators and mediators may exist (Sloan, Marx & Epstein, 2005).  Examining 
mediators and moderators (Frattaroli, 2006), such as whether the level of disclosure is 
related to symptom improvements (Brown & Heimberg, 2001), may help us better 
understand how and for whom expressive writing works.  For example, Brown & 
Heimberg (2001), explored the number of words in each essay (to measure the degree of 
detail) and the number of self-references (to measure the level at which the account was 
personalized) and found the number of self-referenced words had a curvilinear 
relationship with symptom reduction among female rape victims when assessed at one 
month follow-up.  
Future analyses should also examine whether essay topic (e.g. same versus 
different experience across all sessions), vocabulary (e.g., negative emotion words; 
cause/effect words), or essay descriptiveness (e.g., number of words; self-reference 
words) were more likely to be related longer-term improvements among a female drug 
dependent population.   
Furthermore, the present findings suggest that the expressive writing paradigm 
may not have been powerful enough to produce significant benefits above and beyond the 
intensive residential treatment these women were receiving.  This is not to say, however, 
that without a little tweaking of the paradigm, whether in the number of days spent 
writing (e.g., 8 days versus 4 days of writing), or a different instructional set for the 
disclosure condition (e.g., having participants write about the same topic each day; a 
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certain type of trauma [e.g., assault]; or the most significant trauma indicated on the PDS, 
etc.), expressive writing would not have been more effective with this population.   
Study Implications, Future Directions, and Applications 
The present study has a number of important implications.  First, this study 
supports the notion that repeated trauma and PTSD are pervasive among female SUD 
populations.  Results indicate that treatment providers should be aware of the high 
prevalence of trauma among SUD patients, as women with both trauma and SUDs are 
likely to have more severe psychological and physical health problems compared to those 
without trauma and/or PTSD.   
While many treatment providers have expressed concern that integrated trauma 
interventions pose a risk for increasing the individual‘s psychiatric and physical health 
symptoms (Hien, et al., 2004), the present study provides evidence that trauma-focused 
interventions can be incorporated into traditional residential SUD treatment without 
triggering more harm.  This clinical trial also supports the notion that counselors can 
address both problems simultaneously, with evidence that such an approach actually 
contributes to addiction recovery, rather than derailing SUD patients from abstinence 
(Brady, Dansky, Back, Foa, Carroll, 2001; Hien, et al., 2004; Najavits, 2006).   
To the best of our knowledge, this study is the first to examine the utility of the 
expressive writing paradigm with drug dependent women.  Furthermore, the findings 
support compliance to the writing instructions through mood changes that occurred 
following writing sessions, as well as outcomes from the Essay Evaluation Measure.   
The study had a high adherence to the treatment, and both writing groups responded to 
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instructions as anticipated.  Expressive writing participants reported that their writing was 
more personal, meaningful, and revealing of their emotions than control writing 
participants.   
According to the follow-up questionnaire, the majority of women who were in the 
expressive writing condition reported that the writing helped them work through issues 
and problems, and deal more effectively with feelings and emotions related to trauma and 
stress.  Examples of responses (selected randomly) to an open-ended question from the 
Follow-Up Questionnaire (‗Did you find the writing helpful? Why? Why not?‘), can be 
found in Table 14.   
Thus, expressive writing was found to be a brief and cost effective adjunct to 
current residential SUD treatment.  Expressive writings‘ efficacy, efficiency (15-20 
minutes per session over four consecutive days), and cost-effectiveness (the cost of a 
notebook), suggest that writing as a means for disclosing traumatic experiences may be a 
useful adjunct to traditional alcohol and drug treatment, particularly in SUD treatment 
settings that do not routinely screen for trauma and PTSD and therefore, do not 
specifically focus on such issues during treatment.  Overall, the present study revealed 
significant and non-significant improvements across all psychological and physical health 
measures at the one month follow-up for both writing conditions.  Future studies should 
evaluate whether expressive writing affects SUD women with co-morbid PTSD 
differently than women without co-morbid PTSD. 
While the present findings indicate that expressive writing as a trauma-focused 
intervention could be implemented in a residential SUD treatment center without 
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triggering harm, further investigation is still needed in order to understand how 
expressive writing can most appropriately be integrated with, or used as an adjunct to, 
psychotherapeutic techniques currently used in treatment programs.  
Furthermore, the present study was conducted in a residential treatment facility, 
where 24-hour staff was available in the case of any adverse events.  While there were no 
adverse events reported as a result of participating in this study, it is possible that 
participants felt ‗safe‘ being able to write in a confidential setting, where support was 
available if need be.  The author cautions others about conducting this type of clinical 
trial in an outpatient SUD treatment setting, where participants could possibly (and 
likely) go back to an environment where trauma or victimization could occur, especially 
following the written disclosure task.  Therefore, further research is needed to examine if 
benefits of expressive writing could generalize to SUD patients attending outpatient 
treatment. A next step might be to conduct an expressive writing study using methadone 
maintenance treatment patients, where new patients would be required to visit the clinic 
daily.   
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Table 14 
Follow-Up Questionnaire: 10 randomly selected Quotes from Each Writing Condition 
Expressive 
Writing 
Participants 
Question 4:  Did you find the writing helpful? Why? Why not?  
                      (please put your answer below) 
  
 
 “Very helpful. I've never in my life experienced something like this. It 
hit the core of everything” 
 “Because it helped me express some of my feelings that I held inside”                                                                                                                                                                                                                                      
 “It made me realize that what happened to me wasn't my fault” 
 “Because it helped me to bring back to surface some of the stuff I had 
suppressed” 
 “Very helpful.  It got me in touch with my feelings and helped me 
work through some of my issues and problems.  It was good for me” 
 “Made me bring some of the issues that wrote about, especially the 
attempted rape and how I was able to not have sex because of fear” 
 “It helped me share, get out some of my feelings, it's better when 
you're writing things” 
 “Because it's helping me to deal with the things I have gone through.  
My mask came down a little bit.  Now I don't get teary-eyed as often.  
Helped take some off my shoulders”                                                                                                                             
 
 “Very helpful. Helped me to vent everything I've had built up inside”       
 
 “Because it made me think back to some issues that were hindering 
me from moving forward.  It helps me let go and move forward.  I feel 
much better” 
Control Writing 
Participants 
“Shallow subject matter” 
 “It was just being plain, you can't express no emotions”                                                                                                                                                                                                                                                    
 “Kind of neutral! Not aware of what the goal was. Helps me in my 
purpose in gaining knowledge of it”                                                                                                                                                                                                        
 “Gave me insight to how much I remember the previous day's 
events”                                                                                                                                                                                                                                           
 “Because it made me realize that I can write just about anything”                                                                                                                                                                                                                                           
 “Not so much writing about food, but just spending that 20 minutes 
writing, I did”                                                                                                                                                                                                                          
 “It made me think in ways I never thought of and I still think about it 
now”                                                                                                                                                                                                                                 
 “It helped me realize/ remember a lot of things”                                                                                                                                                                                                                                                        
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 “I found out that it was kind of hard trying to remember everything I 
did in a day's time”                                                                                                                                                                                                                  
 “It helped my brain to work so I could remember things” 
 
Study Limitations 
The present study had a number of limitations.  First, one month is a relatively 
short follow-up period.  It is important that future studies examine group differences over 
longer periods of time post-intervention, even though other studies show the most 
dramatic effects more immediately following the intervention.  Another limitation of this 
study is that physical health outcome measures were all based solely on self-report, which 
has a tendency to be a less reliable and less objective measure of health (Sloan, Marx & 
Epstein, 2005).  It would have been useful to include objective data such as 
medical/clinical staff ratings (blind to study condition) as well as absentee rates from 
Rubicon groups and other activities.    
Furthermore, the brief drug craving scale used in this study may have been 
inadequate in detecting true craving levels, and future studies should incorporate other 
measures of craving, or post-residential treatment follow-ups in order to determine 
relative craving and relapse rates once in a non-controlled environment.  Moreover, as 
already pointed out, the present study was conducted in a residential facility and can not 
be generalized to outpatient SUD patient populations.   
As noted earlier, people with more severe mental health problems (e.g., SUDs, 
PTSD, Depression), may require more writing sessions or longer writing session.  It 
would also be useful to examine potential moderators, including questionnaires assessing 
avoidance (high avoidance versus low avoidance personalities).  There is also evidence 
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that expressive writing is more useful with males (Frattaroli, 2006).  Thus, it would be 
important for future research to examine whether gender does in fact impact outcomes, 
particularly with SUD populations. 
Another important consideration when interpreting the findings of the present 
study is that, although participants received scripted instructions for each writing 
condition, participants in the expressive writing condition were not required to address 
any particular experience in their writing.  Thus, expressive writing participants could 
independently choose the topic of disclosure and it could remain constant across the four 
writing sessions or it could vary across sessions.  It would be helpful to determine 
whether participants wrote about the traumatic events they reported on the PDS 
questionnaire, such as a particular assault versus something about a death of a parent, for 
example.   
It is important to note that the primary focus of the present study was on short 
term beneficial or detrimental effects associated with expressive writing, when offered as 
an adjunct to drug abuse treatment.  For safety reasons, this initial RCT was conducted in 
a residential setting and provided benchmark data on short term outcomes associated with 
expressive writing.  Specifically, the study examined whether expressive writing posed 
any increased risk for premature treatment drop out or relapse to substance use.  Outcome 
data supported the safety of the experimental paradigm and yielded no evidence of short-
term negative outcomes relative to the control group.  Because the safety issues were of 
central importance, the present study did not systematically examine whether a focus on 
trauma-related issues early in treatment would also lead to better longer-term outcomes 
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(e.g., lower rates of relapse and re-victimization following discharge from residential 
care).   Since present study findings supported the safety of expressive writing as an 
adjunct to drug abuse treatment, the stage is now set for future studies that include 
longer-term follow-up.  Specifically, subsequent research should track participants post-
intervention over longer periods of time and particularly following discharge from 
residential care, with a focus on physical and psychological functioning as well as relapse 
to drug use.   
No specific questions were asked about the traumatic event(s) chosen as targets 
for expressive writing or the factors that contributed to their selection.  Future data 
analyses will provide more detailed information, with an opportunity to compare essay 
content with PDS assessment results. The present study elected not to specify how 
traumatic events should be selected for focus in expressive writing because research to-
date has yielded mixed results and no studies have focused on women with SUDs.   With 
more general population samples, some research has found beneficial effects regardless 
of instructions, while others found that writing about specific topics was more beneficial.  
This is clearly an area that warrants further attention and could prove important in the use 
of expressive writing as an adjunct to drug abuse treatment. 
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 Appendix A 
 
Overview of writing instructions given to experimental condition 
 
This study is an extremely important project looking at writing.  Over the next 
four days, you will be asked to write about one of several different topics for 20 minutes 
each day.  You will first meet with me at this office and I will give you your instructions.  
You will then be escorted to a comfortable room where you will not be disturbed (e.g., 
you room) and will be alone to write.  The person who brings you to the room will close 
the door: that will be your signal to begin writing.  At the end of 20 minutes, the person 
will knock on your door to let you know that the 20 minutes are up. 
 The only rule we have about your writing is that you write continuously for the 
entire time.  If you run out of things to say, just repeat what you have already written.  In 
your writing, don‘t worry about grammar, spelling, or sentence structure.  Just write.  
Different people will be asked to write about different topics.  Because of this, I ask that 
you not talk with anyone about the experiment.  Because we are trying to make this a 
tight experiment, I can‘t tell you what other people are writing about or anything about 
the nature or predictions of the study.  Once the study is complete, however, we will tell 
you everything.  Another thing is that some people feel a little sad or depressed after 
writing.  If that happens, it is completely normal.  Most people say that these feelings go 
away in an hour or so.  If at any time over the course of the experiment you feel upset or 
distressed, please contact Dr. Dace Svikis or Sarah Meshberg-Cohen immediately [Note: 
All participants will receive a sheet with contact information for Dr. Svikis and Ms. 
Meshberg-Cohen]. 
 Another thing.  Your writing is completely anonymous and confidential.  Your 
booklet is coded with an ID number.  Please do not write your name on the booklet.  I 
promise that none of the experimenters, including me, will link your writing to you.  The 
one exception is that if your writing indicates that you intend to harm yourself or others, 
we are legally bound to match your ID with your name.  Above all, we respect your 
privacy.  Do you have any questions at this point?  Do you still wish to participate? 
 
Experimental Condition Instructions 
 
Over the next four days, I want you to write about your deepest emotions and thoughts 
about the most traumatic experience in your life. In your writing, I‘d like you to really let 
go and explore your very deepest emotions and thoughts.  You might tie this trauma to 
your childhood, your relationship with others, including your parents, lovers, friends, or 
relatives.  You may also link this event to your past, present, or your future, or to who 
you have been, who you would like to be, or who you are now.  You may write about the 
same general issues or experiences on all days of writing or on different topics each day.  
Not everyone has had a single trauma but all of us have had major conflicts or stressors in 
our lives and you can write about them as well. All of your writing will be completely 
confidential.  Don‘t worry about spelling, sentence structure, punctuation or grammar.  
The only rule is that once you begin writing, continue to do so until your time is up.   
 143 
 
On the second day of writing 
 
How did yesterday‘s writing go?  Today, I want you to continue writing about the most 
traumatic experience in your life.  It could be the same topic that you wrote about 
yesterday, or it could be something different.  But today, I really want you to explore 
your very deepest emotions and thoughts… 
 
On the third day of writing 
 
In your writing today, I again want you to explore your deepest thoughts and feelings 
about the most traumatic experience of your life. It could be the same topic that you 
wrote about yesterday, or it could be something different.  But today, I really want you to 
explore your very deepest emotions and thoughts… 
 
On the fourth day of writing 
 
Today is the last writing session.  In your writing today, I again want you to explore your 
deepest thoughts and feelings about the most traumatic experience of your life.  
Remember that this is the last day and so you might want to wrap everything up.  For 
example, how is this experience related to your current life and your future?  But feel free 
to go in any direction you feel most comfortable with and delve into your deepest 
emotions and thoughts… 
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Overview of writing instructions given to control condition 
 
This study is an extremely important project looking at writing.  Over the next 
four days, you will be asked to write about one of several different topics for 20 minutes 
each day.  You will first meet with me at this office and I will give you your instructions.  
You will then be escorted to a comfortable room where you will not be disturbed (e.g., 
you room) and will be alone to write.  The person who brings you to the room will close 
the door: that will be your signal to begin writing.  At the end of 20 minutes, the person 
will knock on your door to let you know that the 20 minutes are up. 
 The only rule we have about your writing is that you write continuously for the 
entire time.  If you run out of things to say, just repeat what you have already written.  In 
your writing, don‘t worry about grammar, spelling, or sentence structure.  Just write.  
Different people will be asked to write about different topics.  Because of this, I ask that 
you not talk with anyone about the experiment.  Because we are trying to make this a 
tight experiment, I can‘t tell you what other people are writing about or anything about 
the nature or predictions of the study.  Once the study is complete, however, we will tell 
you everything.   
 Another thing.  Your writing is completely anonymous and confidential.  Your 
booklet is coded with an ID number.  Please do not write your name on the booklet.  I 
promise that none of the experimenters, including me, will link your writing to you.  The 
one exception is that if your writing indicates that you intend to harm yourself or others, 
we are legally bound to match your ID with your name.  Above all, we respect your 
privacy.  Do you have any questions at this point?  Do you still wish to participate? 
 
 
Control Condition Instructions 
 
Over the next four days, I will give you a writing assignment.  In today‘s writing, I would 
like you to describe what you have eaten since yesterday morning.  I am not interested in 
your emotions or opinions.  Rather I want you to write about specific objects or events in 
detail without discussing your thoughts or feelings.  Feel free to be as detailed as 
possible.  Again, I want you to describe exactly what you have eaten up until coming to 
this experiment.  For example, you might describe the texture, the color, an estimate of 
calories and fat, how big the portions were, what meal you were eating, etc. The most 
important thing in your writing, however, is for you to describe what you ate since 
yesterday as accurately as possible. 
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On the second day of writing 
How did your writing go yesterday? In today‘s writing, I want you to describe what you 
did yesterday from the time you got up until the time you went to bed.  I am not 
interested in your emotions or opinions, but rather I want you to write about specific 
objects or events in detail without discussing your thoughts or feelings.  Feel free to be as 
detailed as possible.  For example, you might start when your alarm went off and you got 
out of bed.  You can include the things you ate, who you sat next to, where you went, 
which buildings or objects you passed as you walked from place to place.  The most 
important thing in your writing, however, is for you to describe your days as accurately 
as possible. 
 
On the third day of writing 
Today, I would like you to describe what you have eaten since yesterday morning after 
you woke up, until the time that you came here for this study.  Again, I want you to be as 
objective as possible and describe exactly what you have eaten up until coming to this 
experiment.  For example, you might describe the texture, the color, an estimate of 
calories and fat, how big the portions were… The most important thing in your writing, 
however, is for you to describe what you ate since yesterday as accurately and as 
objectively as possible. 
 
 
On the fourth day of writing 
This is the last day of writing.  In your writing today, I want you to describe what you 
have done today since you woke up.  Again, I want you to be as objective as possible to 
describe exactly what you have done up until coming to this experiment… 
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Appendix B 
 
 
 
What day did you come to Rubicon?  ____/____/____ 
 
Today‘s date: ____/____/____ 
 
 
Your date of birth: _____/_____/_____   
            Mo.   Day    Yr. 
 
 
Marital Status: 
 Single / Never Married 
 Married 
 Divorced/Separated 
 Widowed 
    
Race/Ethnicity: 
 African – American 
 White – American 
 Asian – American 
 Hispanic 
 Other (specify):______________ 
 
 
Education: 
Last grade completed:_________  
 
Current Employment: 
  
 Homemaker 
 Disability 
 Work Full Time (35 + hrs/week) 
Occupation: ________________ 
 Work Part Time (<35  hrs/week)     
          Occupation: ________________ 
 Student  
At the present time, what is your religious 
preference? 
 Roman Catholic 
 Protestant (Baptist, Episcopal, 
Lutheran, Methodist, Presbyterian, 
etc.) 
 Jewish 
 Muslim 
 Buddhist 
 Other (specify):______________ 
 
 
 
 
 
Please answer the questions below as accurately and honestly as possible.  
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Date: ___________ Researcher: ______________ Research ID: ________ 
 
 
CES-D 
 
 
 
Below is a list of the ways you might have felt or behaved.  Please check the appropriate 
box to tell how often you have felt this way during the past week.  
 
 
Rarely or 
none of the 
time (less 
than 1 day) 
Some or 
a little of 
the time 
(1-2 
days) 
Occasionally 
or a 
moderate 
amount of 
time (3-4 
days)  
Most or all 
of the time 
(5-7 days) 
 
1. I was bothered by things that usually      
don't bother me. 
 
2. I did not feel like eating; my appetite  
was poor.   
 
3.  I felt that I could not shake off the 
blues even with help from my family  
or friends. 
 
4.  I felt I was just as good as other people. 
 
5.  I had trouble keeping my mind on what 
I was doing.  
 
6. I felt depressed.  
 
7.  I felt that everything I did was an  
effort.   
 
8.  I felt hopeful about the future.  
 
9. I thought my life had been a failure.   
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10.  I felt fearful.   
 
11.  My sleep was restless.   
 
12.  I was happy.  
 
13.  I talked less than usual. 
 
14.  I felt lonely.   
 
15.  People were unfriendly.  
 
16.  I enjoyed life.   
 
17.  I had crying spells.   
 
18.  I felt sad.   
 
19.  I felt that people disliked me.   
 
20.  I could not get "going".   
 
  
Rarely or 
none of the 
time (less 
than 1 day) 
Some or 
a little of 
the time 
(1-2 
days) 
Occasionally 
or a 
moderate 
amount of 
time (3-4 
days)  
Most or all 
of the time 
(5-7 days) 
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PANAS 
Directions 
This scale consists of a number of words that describe different feelings and emotions.  
Read each item and then circle the appropriate answer next to that word.  Indicate to what 
extent feel this way right now. 
 
Use the following scale to record your answers. 
 
(1) = Very slightly 
or not at all 
(2) = A little (3) = Moderately (4) = Quite a bit (5) = Extremely 
 
 Very 
slightly or 
not at all 
 
 
A little 
 
 
Moderately 
 
 
Quite a bit 
 
 
Extremely 
1. Interested 1 2 3 4 5 
2. Distressed 1 2 3 4 5 
3. Excited 1 2 3 4 5 
4. Upset 1 2 3 4 5 
5. Strong 1 2 3 4 5 
6. Guilty 1 2 3 4 5 
7. Scared 1 2 3 4 5 
8. Hostile 1 2 3 4 5 
9. Enthusiastic 1 2 3 4 5 
10. Proud 1 2 3 4 5 
11. Irritable 1 2 3 4 5 
12. Alert 1 2 3 4 5 
13. Ashamed 1 2 3 4 5 
14. Inspired 1 2 3 4 5 
15. Nervous 1 2 3 4 5 
16. Determined 1 2 3 4 5 
17. Attentive 1 2 3 4 5 
 150 
18. Jittery 1 2 3 4 5 
19. Active 1 2 3 4 5 
20. Afraid 1 2 3 4 5 
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The PILL 
Several common symptoms or bodily sensations are listed below. Most people have 
experienced most of them at one time or another. We are currently interested in finding 
out how prevalent each symptom is among various groups of people. On the page below, 
write how frequently you experience each symptom. For all items, use the following 
scale: 
 
A B C D E 
Have never or 
almost never 
experienced the 
symptom 
Less than 3 or 
4 
times per year 
 
Every month or 
so 
 
Every week 
or so 
 
More than 
once every 
week 
 
   
For example, if your eyes tend to water once every week or two, you would answer "D" 
next to 
question #1. 
___1. Eyes water       ___28. Swollen joints 
___2. Itchy eyes or skin     ___29. Stiff or sore muscles 
___3. Ringing in ears      ___30. Back pains 
___4. Temporary deafness or hard of hearing               ___31. Sensitive or tender  
skin 
___5. Lump in throat       ___32. Face flushes 
___6. Choking sensations      ___33. Tightness in chest 
___7. Sneezing spells                 ___34. Skin breaks out in  
rash 
___8. Running nose       ___35. Acne or pimples on  
face 
___9. Congested nose      ___36. Acne/pimples other  
than face 
___10. Bleeding nose      ___37. Boils 
___11. Asthma or wheezing      ___38. Sweat even in cold  
weather 
___12. Coughing     ___39. Strong reactions to  
insect bites 
___13. Out of breath       ___40. Headaches 
___14. Swollen ankles      ___41. Feeling pressure in  
head 
___15. Chest pains      ___42. Hot flashes 
___16. Racing heart       ___43. Chills 
___17. Cold hands or feet even in hot weather   ___44. Dizziness 
___18. Leg cramps       ___45. Feel faint 
___19. Insomnia or difficulty sleeping   ___46. Numbness or tingling  
in any part of body 
___20. Toothaches       ___47. Twitching of eyelid 
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___21. Upset stomach      ___48. Twitching other than  
eyelid 
___22. Indigestion       ___49. Hands tremble or  
shake 
___23. Heartburn or gas      ___50. Stiff joints 
___24. Abdominal pain      ___51. Sore muscles 
___25. Diarrhea      ___52. Sore throat 
___26. Constipation       ___53. Sunburn 
___27. Hemorrhoids      ___54. Nausea 
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Brief Substance Craving Scale (BSCS) 
Please answer the following questions with regard to Craving for Drug of Choice: 
Drug of choice: _____________________ 
The INTENSITY of my craving, that is, how much I desired cocaine in the past 24 hours was: 
O - 0 None at 
all 
O - 1 Slight O - 2 Moderate O - 3 Considerable O - 4 
Extreme 
The FREQUENCY of my craving, that is, how often I thought of cocaine in the past 24 hours 
was: 
O - 0 Never O - 1 Almost Never O - 2 Several 
Times 
O - 3 
Regularly 
O - 4 Almost Constantly 
The LENGTH of Time I spent in craving for cocaine during the past 24 hours was: 
O - 0 None at 
all 
O - 1 Very 
Short 
O - 2 Short O - 3 Somewhat Long O - 4 Very 
Long 
 
A 2nd craved drug during the past 24 hours was:      (mark ONLY ONE of the following) 
O - Downers or Sedatives (Barbiturates 
etc.) 
O - Benzos (Valium, Xanex, 
etc.) 
O - Nicotine O - 
Alcohol 
O - Heroin or other Opiates (Morphine, 
etc.) 
O - Cocaine or Crack O - 
Marijuana 
O - 
Others 
 
The INTENSITY of my craving, that is, how much I desired this second drug in the past 24 
hours was: 
O - 0 None at 
all 
O - 1 Slight O - 2 Moderate O - 3 Considerable O - 4 
Extreme 
The FREQUENCY of my craving, that is, how often I thought of this second drug in the past 24 
hours was: 
O - 0 Never O - 1 Almost Never O - 2 Several Times O - 3 Regularly O - 4 Almost 
Constantly 
The LENGTH of Time I spent in craving for this second drug during the past 24 hours was: 
O - 0 None at all O - 1 Very Short O - 2 Short O - 3 Somewhat Long O - 4 Very 
Long 
 
A 3rd craved drug during the past 24 hours was:      (mark ONLY ONE of the following) 
O - Downers or Sedatives (Barbiturates 
etc.) 
O - Benzos (Valium, Xanex, 
etc.) 
O - Nicotine O - 
Alcohol 
O - Heroin or other Opiates (Morphine, 
etc.) 
O - Cocaine or Crack O - 
Marijuana 
O - 
Others 
 
The INTENSITY of my craving, that is, how much I desired this third drug in the past 24 hours 
was: 
O - 0 None at 
all 
O - 1 Slight O - 2 Moderate O - 3 Considerable O - 4 
Extreme 
The FREQUENCY of my craving, that is, how often I thought of this third drug in the past 24 
hours was: 
O - 0 Never O - 1 Almost Never O - 2 Several Times O - 3 Regularly O - 4 Almost 
Constantly 
The LENGTH of Time I spent in craving for this third drug during the past 24 hours was: 
O - 0 None at all O - 1 Very Short O - 2 Short O - 3 Somewhat Long O - 4 Very Long 
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Please indicate the extent to which the following descriptions describe the essay you just 
wrote.  Circle the number that best describes your writing for the following statements:  
 
 
1.  The essay was meaningful. 
 
1 2 3 4 5 6 7 
Not at 
all 
  Neutral   A great 
deal 
                 
2. The essay was personal. 
 
1 2 3 4 5 6 7 
Not at 
all 
  Neutral   A great 
deal 
 
 
3. The essay was revealing of my emotions. 
 
1 2 3 4 5 6 7 
Not at 
all 
  Neutral   A great 
deal 
 
4. I wanted to talk to others about the event(s) that I wrote about. 
 
1 2 3 4 5 6 7 
Not at 
all 
  Neutral   A great 
deal 
 
 
5. I have actually talk to others about the event(s) that I wrote about. 
 
1 2 3 4 5 6 7 
Not at 
all 
  Neutral   A great 
deal 
 
 
6. I have actively held back from talking to others about the event(s) that 
I wrote about. 
 
1 2 3 4 5 6 7 
Not at 
all 
  Neutral   A great 
deal 
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Follow Up Questionnaire 
 
1. Did you hear any clients at Rubicon discussing the writing instructions for this 
study? (please put a check next to your response) 
  
Yes ______     No ______ 
 
2. What do you think the other writing instructions were about? (please put your 
answer below) 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
___________________ 
 
3. Did you tell any other clients at Rubicon about the writing instructions you were 
given for this study? 
 
Yes ______     No ______ 
 
4. Did you find the writing helpful? Why? Why not? (please put your answer below) 
 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
____________________ 
 
5. Did you talk about the subject matter from your essays with anyone during your 
treatment at Rubicon?   
 
Yes ______     No ______ 
 
6. a) If you answer ‗Yes‘ to #5 -- Did you find it helpful to talk about?  
 
Yes ______     No ______ 
 
 
7. Did you continue writing, using the writing instructions given to you during this 
study, after the writing sessions had ended? 
 
Yes ______     No ______ 
 
Thank you! 
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